AI assistant
Ambea — Interim / Quarterly Report 2019
Aug 20, 2019
2999_ir_2019-08-20_25008d11-6772-461e-8f55-4f4ac0c9465d.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
Continued earnings growth with measures in Norway having an impact
Second quarter April–June
- Net sales rose 90 per cent to SEK 2,877 million (1,518). Acquired growth was 88 per cent and organic growth was 1 per cent
- Operating profit (EBIT) declined to SEK 83 million (95)
- EBITA increased 4 per cent to SEK 118 million (114), corresponding to a margin of 4.1 per cent (7.5)
- Adjusted EBITA, excluding items affecting comparability, rose 54 per cent to SEK 175 million (114). The adjusted EBI-TA margin was 6.1 per cent (7.5)
- During the quarter, items affecting comparability amounted to SEK -57 million (0), attributable to integration costs and synergy realisation in connection with the acquisition of Aleris Omsorg
- Profit for the period totalled SEK 12 million (75)
- Earnings per share were SEK 0.16 (1.00) before and SEK 0.16 (1.00) after dilution
- Operating cash flow was SEK 338 million (248)
- Free cash flow totalled SEK 178 million (236)
First six months January–June
- Net sales rose 81 per cent to SEK 5,393 million (2,985). Acquired growth was 79 per cent and organic growth was 2 per cent
- Operating profit (EBIT) declined to SEK 144 million (181)
- EBITA fell 5 per cent to SEK 209 million (218), corresponding to a margin of 3.9 per cent (7.3)
- Adjusted EBITA, excluding items affecting comparability, increased 45 per cent to SEK 323 million (222). The adjusted EBITA margin was 6.0 per cent (7.4)
- Items affecting comparability amounted to SEK -114 million (-4), attributable to integration costs and synergy realisation in connection with the acquisition of Aleris Omsorg
- Profit for the period totalled SEK 22 million (135)
- Earnings per share were SEK 0.29 (1.80) before and SEK 0.29 (1.80) after dilution
- Operating cash flow was SEK 550 million (366)
- Free cash flow totalled SEK 212 million (302)
Significant events during the quarter
- During the quarter, Ambea conducted a rights issue as announced earlier. Ambea received approximately SEK 1,200 million through the issue, which was over-subscribed by 118 per cent. In conjunction with this, the bridge loan raised for the acquisition of Aleris Omsorg was repaid
- The Annual General Meeting on 16 May adopted a warrants programme for Group management and a matching share plan for certain other managers
- In June 2019, an agreement was reached with the seller regarding the final purchase consideration for Aleris Omsorg, with Ambea receiving SEK 5.6 million plus interest.
Consolidated key figures
| 2019 Apr–Jun |
2019 Apr–Jun1 |
2018 Apr–Jun |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆2 % |
2018/2019 Rolling |
2018 Jan–Dec |
∆ % |
|
|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | excl IFRS 16 | 12 months | ||||||||
| Net sales | 2,877 | 2,877 | 1,518 | 90 | 5,393 | 2,985 | 81 | 8,485 | 6,076 | 40 |
| EBITA | 118 | 94 | 114 | 4 | 209 | 218 | -5 | 499 | 508 | -2 |
| Operating margin, EBITA (%) | 4.1 | 3.3 | 7.5 | 3.9 | 7.3 | 5.9 | 8.4 | |||
| Adjusted EBITA | 175 | 151 | 114 | 54 | 323 | 222 | 45 | 648 | 547 | 18 |
| Operating margin, adjusted EBITA (%) | 6.1 | 5.3 | 7.5 | 6.0 | 7.4 | 7.6 | 9.0 | |||
| Operating profit/loss, EBIT | 83 | 59 | 95 | -13 | 144 | 181 | -20 | 393 | 429 | -8 |
| Operating margin, EBIT (%) | 2.9 | 2.1 | 6.3 | 2.7 | 6.1 | 4.6 | 7.1 | |||
| Profit after tax | 12 | 23 | 75 | -84 | 22 | 135 | -84 | 183 | 295 | -38 |
| Earnings/loss per share before dilution, SEK |
0.16 | 0.29 | 1.00 | -84 | 0.29 | 1.80 | -84 | 2.40 | 3.95 | -39 |
| Earnings/loss per share after dilution, SEK |
0.16 | 0.29 | 1.00 | -84 | 0.29 | 1.80 | -84 | 2.40 | 3.94 | -39 |
| Operating cash flow | 338 | 168 | 248 | 36 | 550 | 366 | 50 | 831 | 648 | 28 |
| Free cash flow | 178 | 46 | 236 | -25 | 212 | 302 | -30 | 414 | 506 | -18 |
For definitions of key figures, see Note 9
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.
Comments from Fredrik Gren, President and CEO
Continued earnings growth with measures in Norway having an impact
As we look back on the second quarter, we can see that the intensive restructuring work that commenced in Stendi in March has begun to generate results, at the same time as several steps in the integration of Aleris Omsorg were completed. We have accelerated the pace of opening new units and can see that start-ups are proceeding according to plan regarding both occupancy and a pipeline of competency.
Net sales for the second quarter amounted to SEK 2,877 million (1,518). Own Management accounted for 73 per cent (68) of net sales. Adjusted EBITA rose 54 per cent year-on-year to SEK 175 million (114). Adjusted for the effect of IFRS 16, adjusted EBITA rose 32 per cent to SEK 151 million.
During the quarter, net sales rose SEK 1,359 million, corresponding to 90 per cent, mainly attributable to the acquisition of Aleris Omsorg. Organic net sales increased by 1.4 per cent. In Own Management, net sales rose from SEK 1,034 million to SEK 2,091 million, positively impacted by the Aleris acquisition and start-ups of new units.
Adjusted EBITA rose 54 per cent to SEK 175 million, mainly attributable to high rates of occupancy in existing units, a changed contract mix and acquisitions. IFRS 16 had a positive impact of SEK 24 million on earnings. Vardaga's earnings were strengthened by continued high occupancy of existing units, but were reduced at the same time by the accelerated pace of new openings. Nytida displayed a favourable trend in LSS and an improvement in social care for children and young people. The programme to optimise overlapping capacity in Nytida after the acquisition of Aleris has begun to generate results. For Altiden, the quarter was negatively impacted by higher costs of building up a separate organisation and strengthening it for future growth. Klara's profitability was strengthened as a result of the continued restructuring to accommodate subscription services and the enhanced efficiency of administrative functions.
The restructuring programme that commenced in Stendi in March began to generate results during the quarter. We are now introducing the operating model that we have developed in Sweden.
During the quarter, several major steps in the integration of Aleris Omsorg were completed and we can confirm the plan announced earlier to achieve synergies at an annual rate of SEK 90 million towards the end of the year. Our focus is now on narrowing the margin gap between the Aleris units acquired compared with corresponding existing Ambea units in each sector.
During the quarter, Vardaga, opened three nursing homes with a total of 174 beds and Nytida opened a group home with six beds and a extension of the existing school operations by 21 places. Altiden opened a residential facility with five beds and Stendi opened a residential facility with three beds. The interest from jobseekers has far exceeded the recruitment requirements

of our newly started residential facilities, which demonstrates Ambea's strength in pipeline of competency and its position as an attractive employer. During the past year, Ambea has digitised its recruitment process to secure new employees for our operations. Our pipeline of new units remains high and forms the foundation for future organic growth. At the end of the quarter, the number of beds in the pipeline was 2,167, representing 26 per cent of the number of beds under Own Management.
After the end of the quarter, the first bolt-on acquisition was made since the announcement of the Aleris acquisition and we welcome Pusselbiten School to Ambea Group. Pusselbiten School strengthens Nytida's offering in special needs schools and after-school in Skåne.
During the quarter, we defended several key management contracts, corresponding to total annual sales of SEK 87 million and were able to secure a continued high share of profit in, particularly, quality procurement processes. In addition, we won procurements totalling SEK 9 million in annual sales during the second quarter.
Our focus on quality again displayed favourable results during the quarter, with a survey showing that more than 97 per cent of residents in Altiden's nursing homes would recommend Altiden to others.
The second quarter can be summarised by improved earnings, while taken measures in Norway started to have an impact and we began our journey towards closing the margin gap in acquired Aleris units.
Fredrik Gren
Group
Second quarter
Net sales
Net sales rose 90 per cent to SEK 2,877 million (1,518). Organic sales growth was 1.4 per cent year-on-year.
Net sales in Own Management amounted to SEK 2,091 million (1,034), up 102 per cent compared with the year-earlier period, due to the acquisition of Aleris Omsorg and start-up units.
Net sales in Contract Management amounted to SEK 710 million (401). The year-onyear increase in sales was due to the acquisition of Aleris Omsorg, but was offset by contracts terminated in 2018. Excluding the acquisition, sales in Contract Management declined SEK 21 million compared with the year-earlier period. Municipalities in Norway took back unprofitable contracts within elderly care of 144 MSEK in total annual sales during the quarter.
Net sales in Staffing declined 8 per cent to SEK 76 million (83).
Earnings
EBIT fell 13 per cent to SEK 83 million (95), corresponding to a margin of 2.9 per cent (6.3).
EBITA rose 4 per cent to SEK 118 million (114). The EBITA margin was 4.1 per cent (7.5). EBITA for the quarter was impacted by items affecting comparability of SEK -57 million (0), attributable to integration and synergy-realisation costs for the acquisition of Aleris Omsorg.
Adjusted EBITA for the quarter rose 54 per cent to SEK 175 million (114). Acquisitions completed earlier and start-up units had a positive impact on earnings. The adjusted EBITA margin was 6.1 per cent (7.5). Excluding the effects of IFRS 16, the adjusted EBITA margin was 5.3 per cent. IFRS 16 had a positive impact on EBITA of SEK 24 million for the quarter.
Net financial items
During the quarter, net financial items amounted to SEK -67 million (-3). The change was due to the effects of IFRS 16 of SEK 38 million and increased interest expense associated with financing the acquisition of Aleris Omsorg.
Income tax
Tax expense for the period was SEK 4 million (17), corresponding to an effective tax rate of 22 per cent (22).
Profit for the period
Profit for the period was SEK 12 million (75), corresponding to earnings per share of SEK 0.29 (1.00) before dilution and SEK 0.29 (1.00) after dilution.
Net sales by segment April – June 2019

Net sales by contract model April – June 2019

Distribution of net sales
| Net sales by segment | 2019 Apr–Jun |
2018 Apr–Jun |
|---|---|---|
| Vardaga | 30% | 37% |
| Nytida | 33% | 49% |
| Stendi | 30% | 9% |
| Altiden | 4% | – |
| Klara | 3% | 5% |
| Total | 100% | 100% |
| Net sales by contract model | 2019 Apr–Jun |
2018 Apr–Jun |
|---|---|---|
| Own management | 73% | 68% |
| Contract Management | 24% | 26% |
| Staffing | 3% | 6% |
| Total | 100% | 100% |
Distribution of net sales
| Own Management | Contract Management | Staffing | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
% | 2019 Apr–Jun |
2018 Apr–Jun |
% | 2019 Apr–Jun |
2018 Apr–Jun |
% | 2019 Apr–Jun |
2018 Apr–Jun |
% |
| Vardaga | 517 | 280 | 84 | 362 | 276 | 31 | – | – | – | 879 | 556 | 58 |
| Nytida | 818 | 622 | 32 | 122 | 125 | 2 | – | – | – | 940 | 747 | 26 |
| Stendi | 742 | 131 | 466 | 111 | – | – | – | – | – | 853 | 131 | 551 |
| Altiden | 14 | – | 115 | – | – | – | – | – | 129 | – | – | |
| Klara | – | – | – | – | – | 76 | 83 | -8 | 76 | 83 | -8 | |
| Group | 2,091 | 1,034 | 102 | 710 | 401 | 79 | 76 | 83 | -8 | 2,877 | 1,518 | 90 |
Own Management – total in operation, including acquisitions
| OB | Change | CB | |||||
|---|---|---|---|---|---|---|---|
| SEK million | Units | Beds/ Placements |
Units | Beds/ Placements |
Units | Beds/ Placements |
|
| Vardaga – beds | 41 | 2,139 | 3 | 174 | 44 | 2,313 | |
| Vardaga – home-care customers | – | 2,305 | – | 7 | – | 2,312 | |
| Nytida – beds | 222 | 2,465 | – | -211 | 222 | 2,444 | |
| Nytida – placements | 91 | 2,705 | – | 21 | 91 | 2,726 | |
| Stendi – beds | 430 | 881 | 4 | 42 | 434 | 923 | |
| Stendi – home-care customers | – | 18 | – | 1 | – | 19 | |
| Altiden – beds | 2 | 30 | 1 | 5 | 3 | 35 | |
| Altiden – home-care customers | – | 1,9382 | – | 31 | – | 1,969 | |
| Total beds and placements | 786 | 8,220 | 8 | 221 | 794 | 8,441 | |
| Total home-care customers | – | 4,261 | – | 39 | – | 4,300 |
Own Management – pipeline
| Quarterly change | ||||||||
|---|---|---|---|---|---|---|---|---|
| SEK million | OB | Opened during the quarter |
New during the quarter3 |
CB | ||||
| Vardaga | 1,964 | 174 | 120 | 1,910 | ||||
| Nytida – beds | 1794 | 16 | 17 | 180 | ||||
| Nytida – placements | 21 | 21 | – | – | ||||
| Stendi | 3 | 3 | – | – | ||||
| Altiden | 77 | 5 | 5 | 77 | ||||
| Total | 2,244 | 219 | 142 | 2,167 |
Contract Management – pipeline
| Allocation decisions during the quarter5 | Started-up/terminated | |||
|---|---|---|---|---|
| SEK million | Units | Beds | Annual revenue | during the quarter Annual revenue6 |
| Won | 1 | 6 | 9 | 8 |
| Renewed confidence | 13 | 106 | 87 | – |
| Lost | – | – | – | 77 |
| Handed back to municipal management | 1 | 56 | 4 | 144 |
1 The net change in the number of units and beds in Nytida includes the closure of two residential treatment centres for substance abuse as part of the programme announced earlier to optimise overlapping capacity.
2 Opening balance adjusted by 743 customers.
3 New refers to the total sum of signed contracts and units under construction. For more information about expected opening dates, refer to Own Management – Pipeline under ambea.com/investor-relations/
4 Opening balance adjusted by 10 beds.
5 Allocation decisions during the quarter mean that Ambea has received decisions during the quarter about contracts that are to be handed back or started up. The period of time between allocation and handback/start-up ranges
from a couple of months to one year. About 9–12 months for Vardaga, and 6–9 months for Nytida.
6 Shows the contracts started up or handed back during the quarter and their annual revenue.
7 Sales of SEK 3 million pertain to units from the acquisition of Aleris Omsorg for the period from the transfer date.
Group
January – June
Net sales
Net sales rose 81 per cent to SEK 5,393 million (2,985). Organic sales growth was 1.6 per cent year-on-year.
Net sales in Own Management amounted to SEK 3,895 million (2,020), up 92 per cent compared with the year-earlier period, due to the acquisition of Aleris Omsorg and start-up units.
Net sales under Contract Management amounted to SEK 1,339 million (804), an increase of 67 per cent. The year-on-year increase in sales was due to the acquisition of Aleris Omsorg, but was offset by contracts terminated in 2018.
Net sales in Staffing declined 3 per cent to SEK 155 million (161).
Earnings
EBIT fell 20 per cent to SEK 144 million (181), corresponding to a margin of 2.7 per cent (6.1).
EBITA declined 5 per cent to SEK 209 million (218). The EBITA margin was 3.9 per cent (7.3). EBITA for the period was impacted by items affecting comparability of SEK -114 million (-4), attributable to integration and synergy-realisation costs for the acquisition of Aleris Omsorg.
Adjusted EBITA for the period rose 45 per cent to SEK 323 million (222). Acquisitions completed earlier and start-up units had a positive impact on earnings. The adjusted EBITA margin was 6.0 per cent (7.4). Excluding IFRS 16, the adjusted EBITA margin was 5.2 per cent. IFRS 16 effected EBITA positively by 42 MSEK in the period.
Net financial items
During the quarter, net financial items amounted to SEK -116 million (-12). The change was due to the effects of IFRS 16 of SEK 74 million and increased interest expense associated with financing the acquisition of Aleris Omsorg.
Income tax
Tax expense for the period was SEK 6 million (34), corresponding to a tax rate of 22 per cent (22).
Profit for the period
Profit for the period amounted to SEK 22 million (135), corresponding to earnings per share before dilution of SEK 0.29 (1.80) and earnings per share after dilution of SEK
Net sales by segment January–June 2019

Net sales by contract model January–June 2019

Distribution of net sales
| Net sales by segment | 2019 Jan–Jun |
2018 Jan–Jun |
|---|---|---|
| Vardaga | 31% | 37% |
| Nytida | 34% | 49% |
| Stendi | 28% | 9% |
| Altiden | 4% | – |
| Klara | 3% | 5% |
| Total | 100% | 100% |
| Net sales by contract model | 2019 Jan–Jun |
2018 Jan–Jun |
|---|---|---|
| Own Management | 72% | 68% |
| Contract Management | 25% | 27% |
| Staffing | 3% | 5% |
| Total | 100% | 100% |
Distribution of net sales
| Own Management | Contract Management | Staffing | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2019 Jan–Jun |
2018 Jan–Jun |
% | 2019 Jan–Jun |
2018 Jan–Jun |
% | 2019 Jan–Jun |
2018 Jan–Jun |
% | 2019 Jan–Jun |
2018 Jan–Jun |
% |
| Vardaga | 971 | 550 | 77 | 704 | 557 | 26 | – | – | – | 1,675 | 1,107 | 51 |
| Nytida | 1,578 | 1,217 | 29 | 235 | 247 | -1 | – | – | – | 1,813 | 1,464 | 24 |
| Stendi | 1,321 | 253 | 426 | 203 | – | – | – | – | – | 1,524 | 253 | 502 |
| Altiden | 26 | – | – | 200 | – | – | – | – | – | 226 | – | – |
| Klara | – | – | – | – | – | – | 155 | 161 | -4 | 155 | 161 | -4 |
| Group | 3,896 | 2,020 | 92 | 1,342 | 804 | 68 | 155 | 161 | -4 | 5,393 | 2,985 | 81 |
Cash flow
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| Cash flow from operating activities before changes in working capital |
171 | 120 | 331 | 197 | 599 | 465 |
| Cash flow from changes in working capital | 47 | 127 | -59 | 121 | -107 | 74 |
| From operating activities | 218 | 247 | 272 | 318 | 491 | 538 |
| Cash flow from investing activities (excluding acquisitions/divest ments and investments in financial assets) |
-40 | -11 | -60 | -16 | -77 | -32 |
| Free cash flow | 178 | 236 | 212 | 302 | 414 | 506 |
Free cash flow for the quarter amounted to SEK 178 million (236). The year-on-year decline in free cash flow was largely due to calendar effects on tied-up working capital and increased investments in new units.
In Norway, earned holiday pay of approximately NOK 65 million was paid during the quarter. Holiday pay in Norway is paid once per year, while it is expensed in line with the actual
holidays taken. In Sweden, holiday pay is expensed and paid in conjunction with actual holidays taken.
The adoption of IFRS 16 had a positive impact on cash flow from operating activities of SEK 132 million year-on-year. The acquisition of Aleris's care operations had a negative impact on cash flow of SEK -1 million during the quarter.
Financial position
| SEK million | 30 Jun 2019 |
30 Jun 20191 excl. IFRS 16 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|---|
| Net interest-bearing debt | 7,848 | 3,525 | 2,193 | 1,993 |
| Equity/assets ratio (%) | 27.9 | 40.7 | 43.5 | 46.7 |
| Net debt/Rolling 12 months adjusted EBITDA | 7.8 | 5.2 | 4.0 | 3.3 |
For definitions of key figures, see Note 9
At 30 June 2019, net debt amounted to SEK 7,848 million (2,193), or 7.8 times rolling 12 months adjusted EBITDA. The increase in net debt was attributable to a higher borrowing within existing credit frameworks as a result of the acquisition of Aleris's care operations and a lease liability recognised in accordance with IFRS 16.
At the balance-sheet date, equity amounted to SEK 3,864 million, compared with SEK 2,707 million at 31 December 2018. The adoption of IFRS 16 had a positive impact of SEK 11 million on equity.
1 Alternative performance measures.
Vardaga
At Vardaga's just over 100 residential care facilities across Sweden, we provide elderly care where every day is as meaningful as the next. Every one of our nursing homes, short-term accommodation units, home care and day services offers a high level of expertise and a safe environment. Our employees ensure quality of life and safety for every care receiver.
Quarter
Vardaga's net sales rose 58 per cent year-on-year to SEK 879 million (556).
Net sales in Own Management rose 84 per cent to SEK 517 million (280) due to the acquisition of Aleris Omsorg and to start-up units.
Net sales in Contract Management amounted to SEK 362 million (276). The 30 per cent increase was due to a positive impact from the acquisition of Aleris Omsorg, reduced by lost contracts in existing operations. During the quarter, Vardaga defended contracts corresponding to an annual volume of SEK 22 million.
EBITA rose 3 per cent to SEK 34 million (33). The acquisition of Aleris Omsorg and favourable occupancy rates at units started already under Own Management made a positive contribution to EBITA, while costs for start-ups were charged to earnings. Calendar effects had a negative impact on earnings compared with the preceding year.
The EBITA margin was 3.9 per cent (5.9). Excluding the effects of IFRS 16, the margin declined 3.5 percentage points to 2.4 per cent. The margin decline was attributable to higher number of start-ups under Own Management and the acquisition of Aleris Omsorg. The EBITA margin for comparable units was positively impacted by a higher share of operations under Own Management and favourable occupancy rates.
January–June period
Vardaga's net sales rose 51 per cent year-on-year to SEK 1,676 million (1,107).
Net sales in Own Management rose 77 per cent to SEK 971 million (550) due to the acquisition of Aleris Omsorg and to start-up units.
Net sales in Contract Management amounted to SEK 704 million (557). The 26 per cent increase was due to a positive impact from the acquisition of Aleris Omsorg, reduced by lost contracts in existing operations.
EBITA rose 26 per cent to SEK 86 million (68). The acquisition of Aleris Omsorg and increased occupancy rate of newly opened units that were under start-up made a positive contribution, while start-ups of new operations had a negative impact.
The EBITA margin was 5.1 per cent (6.1). The reduced margin was mainly attributable to the acquisition of Aleris Omsorg together with the start-up of new units.

Vardaga's operating margin (EBITA), RTM %

| SEK million | 2019 Apr–Jun |
2019 Apr–Jun1 excl. IFRS 16 |
2018 April–June |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆ % |
2018/2019 Rolling 12 months |
2018 Full-year |
∆ % |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 879 | 879 | 556 | 58 | 1,675 | 1,107 | 51 | 2,792 | 2,224 | 26 |
| EBITA | 34 | 21 | 33 | 3 | 86 | 68 | 24 | 176 | 159 | 11 |
| Operating margin, EBITA (%) | 3.9 | 2.4 | 5.9 | 5.1 | 6.1 | 6.3 | 7.1 | |||
| Operating margin EBITA comparable units (%) |
10.0 | 8.5 | 6.4 | 10.2 | 6.7 | 9.4 | 7.6 |
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.
Own Management – total in operation
| OB | Quarterly change | CB | |||||
|---|---|---|---|---|---|---|---|
| Units | Beds | Units | Beds | Units | Beds | ||
| Beds | 41 | 2,139 | 3 | 174 | 44 | 2,313 | |
| Home-care customers | – | 2,305 | – | 7 | – | 2,312 |
Own Management – pipeline
| Quarterly change | ||||||
|---|---|---|---|---|---|---|
| OB | New during the quarter1 |
CB | ||||
| Beds | 1,964 | 174 | 120 | 1,910 |
Contract Management – pipeline
| Allocation decisions during the quarter2 | Started-up/terminated during the quarter |
|||
|---|---|---|---|---|
| Units | Beds | Annual revenue | Annual revenue 3 |
|
| Won | – | – – |
– | |
| Renewed confidence | 1 | 40 | 22 | – |
| Lost | – | – – |
34 | |
| Handed back to municipal management | – | – – |
– |
1 New refers to the total sum of signed contracts and units under construction. For more information about expected opening dates, refer to Own Management – Pipeline under ambea.com/investor-relations/
2 Allocation decisions during the quarter mean that Ambea has received decisions during the quarter about contracts that are to be handed back or started up. The period of time between allocation and handback/start-up varies, but generally amounts to about 9-12 months for Vardaga.
3 Shows the contracts started up or handed back during the quarter and their annual revenue.
4 Pertain to units from the acquisition of Aleris Omsorg for the period from the transfer date.
Nytida
Nytida provides support and care for children, young people and adults with lifelong disabilities and psychosocial problems. We provide residential care, day services, support for individuals and families, and schools in approximately 400 units across Sweden. Using proven models and in-depth knowledge, our 8,500 employees help to strengthen the ability of individuals to live an independent life.
Quarter
Net sales rose 26 per cent to SEK 940 million (747).
Net sales in Own Management amounted to SEK 818 million (622), up 32 per cent. Growth was attributable to the acquisition of Aleris Omsorg and to start-up units.
Net sales in Contract Management amounted to SEK 122 million (125). The decline in sales was due to contracts terminated in 2018. During the quarter, Nytida secured contracts corresponding to an annual volume of SEK 9 million, while the municipalities announced that they would take back annual revenue corresponding to SEK 4 million. During the quarter, contracts corresponding to annual sales of SEK 4 million were terminated, while the effect of new start-up contracts amounted to annual revenue of SEK 8 million.
EBITA rose 44 per cent to SEK 115 million (80). The acquisition of Aleris Omsorg and a favourable occupancy rate at established units under Own Management made a positive contribution to earnings. Calendar effects had a negative impact on Nytida's earnings compared with the preceding year. The development in social care for children & youth contributed positively compared with the preceding year.
During the second quarter, continued activities were conducted as part of the programme announced earlier to optimise overlapping capacity. The positive earnings effect achieved as a result of the action programme is expected to increase during the latter part of the year.
The EBITA margin was 12.2 per cent (10.7).
After the end of the quarter, Nytida acquired Pusselbiten School, which offers special needs activities for children and young people in Skåne.
January–June period
Net sales rose 24 per cent to SEK 1,813 million (1,464).
Net sales in Own Management amounted to SEK 1,578 million (1,217), up 30 per cent. Growth was attributable to the acquisition of Aleris Omsorg and to start-up units.
Net sales in Contract Management amounted to SEK 235 million (247), down 4 per cent and attributable to terminated contracts.
EBITA rose 40 per cent to SEK 218 million (156). The acquisition of Aleris Omsorg makes a positive contribution. During the first quarter, an action programme commenced to reduce overlapping activities due to the acquisition of Aleris. The annual effect of the action programme is deemed to amount to approximately SEK 24 million. The impact on earnings is expected to be gradual, starting in the second quarter.
The EBITA margin was 12.0 per cent (10.7).
| SEK million | 2019 Apr–Jun |
2019 Apr–Jun1 excl IFRS 16 |
2018 Apr–Jun |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆ % |
2018/2019 Rolling 12 months |
2018 Full-year |
∆ % |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 940 | 940 | 747 | 26 | 1,813 | 1,464 | 24 | 3,331 | 2,982 | 12 |
| EBITA | 115 | 106 | 80 | 44 | 218 | 156 | 40 | 430 | 369 | 16 |
| Operating margin, EBITA (%) | 12.2 | 11.3 | 10.7 | 12.0 | 10.7 | 12.9 | 12.3 |
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.

Nytida's operating margin (EBITA), RTM

Own Management – total in operation
| OB | Quarterly change1 | CB | ||||
|---|---|---|---|---|---|---|
| Beds/ | Beds/ | Beds/ | ||||
| Beds | Units | Placements | Units | Placements | Units | Placements |
| 222 | 2,465 | – | -21 | 222 | 2,444 | |
| Placements | 91 | 2,705 | – | 21 | 91 | 2,726 |
Own Management – pipeline
| Quarterly change | ||||||
|---|---|---|---|---|---|---|
| OB | Opened during the quarter |
New during the quarter2 |
CB | |||
| Beds | 1793 | 16 | 17 | 180 | ||
| Placements | 21 | 21 | – | – |
Contract Management – pipeline
| Allocation decisions during the quarter4 | Started-up/terminated during the quarter |
|||
|---|---|---|---|---|
| Units | Beds | Annual revenue | Annual revenue 5 |
|
| Won | 1 | 6 | 9 | 8 |
| Renewed confidence | 12 | 66 | 65 | – |
| Lost | – | – | – | 4 |
| Handed back to municipal management | 1 | 56 | 4 | – |
1 The net change in the number of units and beds in Nytida includes the closure of two residential treatment centres for substance abuse as part of the programme announced earlier to optimise overlapping capacity.
2 New refers to the total sum of signed contracts and units under construction. For more information about expected opening dates, refer to Own Management – Pipeline under ambea.com/investor-relations/
3 Opening balance adjusted by 10 beds.
3 Allocation decisions during the quarter mean that Ambea has received decisions during the quarter about contracts that are to be handed back or started up. The period of time between allocation and handback/start-up varies, but generally amounts to about 6-9 months for Nytida.
4 Shows the contracts started up or handed back during the quarter and their annual revenue.
Stendi
Stendi is the largest care provider in Norway and runs nationwide operations in support and residential care for adults, children and young people. Stendi also provides personal assistance, elderly care and home care services. Stendi has about 5,000 employees and more than 400 units across Norway.
Quarter
Net sales rose 551 per cent to SEK 853 million (131). The increase was largely due to the acquisition of Aleris Omsorg. During the quarter, acquired units with low occupancy rates were closed according to plan. Currency effects on sales in comparable existing units had a positive impact of SEK 3 million year-on-year.
Net sales in Own Management amounted to SEK 742 million (130), up 568 per cent. Growth was attributable to the acquisition of Aleris Omsorg.
Net sales in Contract Management amounted to SEK 111 million (0), and the entire increase was attributable to the acquisition of Aleris's care operations. Contracts were retaken during the period in an amount corresponding to annual revenue of SEK 144 million. The retaken contracts are not deemed to have any negative impact on earnings.
EBITA rose 67 per cent to SEK 10 million (6). The increase was largely due to the acquisition of Aleris Omsorg. During the first quarter, a major restructuring programme commenced in Stendi to implement Ambea's operational model. In the second quarter, early positive EBITA effects of the programme were noted.
The EBITA margin was 1.2 per cent (4.6).
January–June period
Net sales amounted to SEK 1,524 million (253). The increase was largely due to the acquisition of Aleris Omsorg. Currency effects on sales in comparable existing units had a positive impact of SEK 6 million year-on-year.
Net sales in Own Management amounted to SEK 1,320 million (251), up 425 per cent. Growth was attributable to the acquisition of Aleris Omsorg.
Net sales in Contract Management amounted to SEK 203 million (0), and the entire increase was attributable to the acquisition of Aleris's care operations. During the period, one contract management unit was closed.
EBITA was SEK -9 million (9). During the first quarter, a major restructuring programme was initiated to address the negative earnings trend that commenced in the operations of the acquired company Aleris Omsorg in November 2018. Ambea's management model involving a larger number of the company's own employees was introduced to ensure quality and economic stability. During the quarter, vacant capacity related to acquired units was closed down, and the costs were charged to the transfer balance for Aleris's care operations. For more information, refer to Note 5. The annual effect of the programme is an estimated SEK 8 million with a gradual start in the second quarter, in addition to the measures now being implemented and which displayed positive results during the second quarter to increase profitability and management.
The EBITA margin was -0.6 per cent (3.6).
| SEK million | 2019 Apr–Jun |
2019 Apr–Jun1 excl IFRS 16 |
2018 Apr–Jun |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆ % |
2018/2019 Rolling 12 months |
2018 Full-year |
∆ % |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 853 | 853 | 131 | 551 | 1,524 | 253 | 502 | 1,820 | 548 | 178 |
| EBITA | 10 | 9 | 6 | 67 | -9 | 9 | n/a | 16 | 33 | -127 |
| Operating margin, EBITA (%) | 1.2 | 1.1 | 4.6 | -0.6 | 3.6 | 0.9 | 6.0 |
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.

Stendi's operating margin (EBITA), RTM %

Own Management – total in operation
| OB Beds/ Units Placements |
Quarterly change Beds/ Units Placements |
CB Beds/ Units Placements |
||||
|---|---|---|---|---|---|---|
| Beds | 430 | 881 | 4 | 42 | 434 | 923 |
| Home-care customers | – | 18 | – | 1 | – | 19 |
Own Management – pipeline
| Quarterly change | ||||||
|---|---|---|---|---|---|---|
| Opened during the New during the OB quarter quarter1 |
CB | |||||
| Beds | 3 | 3 | – | – |
Contract Management – pipeline
| Allocation decisions during the quarter2 | Started-up/terminated during the quarter |
|||
|---|---|---|---|---|
| Units | Beds | Annual revenue | Annual revenue 3 |
|
| Won | – | – – |
– | |
| Renewed confidence | – | – – |
– | |
| Lost | – | – – |
– | |
| Handed back to municipal management | – | – – |
144 |
1 New refers to the total sum of signed contracts and units under construction. For more information about expected opening dates, refer to Own Management – Pipeline under ambea.com/investor-relations/
2 Allocation decisions during the quarter mean that Ambea has received decisions during the quarter about contracts
that are to be handed back or started up. The period of time between allocation and handback/start-up varies.
3 Shows the contracts started up or handed back during the quarter and their annual revenue.
Altiden
Altiden is the largest private care provider in Denmark, with operations comprising elderly care, home care, rehabilitation and disability care. All over Denmark, we provide skilled care services based on respect. Approximately 1,000 employees ensure quality of life and a safe environment with a focus on development.
Quarter
Net sales amounted to SEK 129 million (0). All of Altiden's operations comprise units from the acquisition of Aleris Omsorg.
Net sales in Own Management amounted to SEK 14 million (0). During the quarter, the start-up of previously opened units progressed as planned.
Net sales in Contract Management amounted to SEK 116 million (0). No new allocation decisions were announced during the quarter. No management contracts were started up or terminated during the quarter.
EBITA was SEK -5 million (0). EBITA was negatively impacted by higher costs to build up a separate organisation in Altiden and strengthening it for future growth.
The EBITA margin was -3.9 per cent (0).
January–June period
Net sales amounted to SEK 226 million (0). All of Altiden's operations comprise units from the acquisition of Aleris Omsorg.
Net sales in Own Management amounted to SEK 26 million (0). During the quarter, the start-up of previously opened units progressed as planned.
Net sales in Contract Management amounted to SEK 200 million (0). No new allocation decisions were announced during the period. No management contracts were started up or terminated during the quarter.
EBITA was SEK -5 million (0). EBITA was negatively impacted by higher costs to build up a separate organisation in Altiden and strengthening it for future growth.
The EBITA margin was -2.2 per cent (0).
| SEK million | 2019 Apr–Jun |
2019 Apr–Jun1 excl IFRS 16 |
2018 Apr–Jun |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆ % |
2018/2019 Rolling 12 months |
2018 Full-year |
∆ % |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 129 | 129 | – | – | 226 | – | – | 226 | – | – |
| EBITA | -5 | -5 | – | – | -5 | – | – | -5 | – | – |
| Operating margin, EBITA (%) | -3.9 | -3.9 | – | -2.2 | – | -2.2 | – |
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.

Own Management – total in operation
| Units | OB | Beds/ Placements |
Units | Quarterly change Beds/ Placements |
Units | CB Beds/ Placements |
|
|---|---|---|---|---|---|---|---|
| Beds | 2 | 30 | 1 | 5 | 3 35 |
||
| Home-care customers | – | 1,9381 | – | 31 | – 1,969 |
Own Management – pipeline
| Quarterly change | ||||||
|---|---|---|---|---|---|---|
| OB | Opened during the quarter |
New during the quarter2 |
CB | |||
| Beds | 77 | 5 | 5 | 77 |
Contract Management – pipeline
| Allocation decisions during the quarter3 | Started-up/terminated during the quarter |
||||
|---|---|---|---|---|---|
| Units | Beds | Annual revenue | Annual revenue 4 |
||
| Won | – | – | – | – | |
| Renewed confidence | – | – | – | – | |
| Lost | – | – | – | – | |
| Handed back to municipal management | – | – | – | – |
1 Opening balance adjusted by 743 customers.
2 New refers to the total sum of signed contracts and units under construction. For more information about expected opening dates, refer to Own Management – Pipeline under ambea.com/investor-relations/
3 Allocation decisions during the quarter mean that Ambea has received decisions during the quarter about contracts
that are to be handed back or started up. The period of time between allocation and handback/start-up varies.
4 Shows the contracts started up or handed back during the quarter and their annual revenue.
Klara
Klara is one of Sweden's leading providers of staffing services for social care. We are an authorised staffing company and are ISO certified. With personal service and long experience in the industry, Klara provides the best staffing solutions for both public and private clients. We mediate thousands of assignments every year and conduct operations throughout Sweden.
Quarter
Net sales declined 8 per cent to SEK 76 million (83). Two thirds of sales comprise revenue from customers in the public sector. The decline is attributable to a negative trend in the supply of temporary doctors and nurses to the private customer segment. The decline was partly offset by increased sales in Klara Team, which offers qualified on-call services on a subscription basis.
EBITA was SEK 6 million (4), representing a margin of 8.0 per cent (5.3). The performance of Klara Team and effects of the previously completed adaptation of administrative costs had a positive impact.
In June 2018, the Supreme Administrative Court issued a decision regarding VAT liability for staffing agencies supplying temporary care staff. For Klara, these new guidelines from the Swedish Tax Agency entail that the supply of temporary care staff to municipalities, counties and private social care companies will be subject to VAT from 1 July 2019. Ambea assesses that this regulatory change will lead to a need for new business models and probably result in lower sales, but also have a limited effect on Klara's earnings. Some of the administrative cost-savings programme implemented in 2018 specifically addressed the need to adapt the cost mass in the staffing operations.
January–June period
Net sales declined 4 per cent to SEK 155 million (161). Two thirds of sales comprise revenue from customers in the public sector. The decline is attributable to a negative trend, primarily in the hiring out of nurses. The reduced sales from the hiring out of nurses was partly offset by increased sales in Klara Team, which offers qualified oncall services on a subscription basis.
EBITA was SEK 11 million (7), representing a margin of 6.9 per cent (4.3). The performance of Klara Team and effects of the previously completed adaptation of administrative costs had a positive impact.
| SEK million | 2019 Apr–Jun |
2019 Apr–Jun1 excl IFRS 16 |
2018 Apr–Jun |
∆2 % |
2019 Jan–Jun |
2018 Jan–Jun |
∆ % |
2018/2019 Rolling 12 months |
2018 Full-year |
∆ % |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 76 | 76 | 83 | -8 | 155 | 161 | -4 | 315 | 321 | -2 |
| EBITA | 6 | 6 | 4 | 50 | 11 | 7 | 57 | 19 | 16 | 19 |
| Operating margin, EBITA (%) | 7.9 | 7.9 | 4.8 | 7.1 | 4.3 | 6.0 | 5.0 |
1 Alternative performance measures.
2 Related to the change between Apr-Jun 2018 and Apr-Jun 2019 with account for IFRS 16.
Other events
New share issue
Following authorisation at the Annual General Meeting on 16 May, Ambea conducted a rights issue of 27,001,440 shares with the aim of repaying part of the financing of the acquisition of Aleris's care operations in Sweden, Norway and Denmark. As a result of the rights issue, the number of shares in Ambea increased, amounting to 94,617,996 shares on the final trading day of the quarter (28 June). Ambea obtained approximately SEK 1,200 million from the rights issue and recognised issue expenses of SEK 17 million.
Incentive programmes
The Annual General Meeting on 16 May 2019 resolved to introduce two new longterm incentive programmes: (i) a warrants programme for Group management and (ii) a matching share plan for certain employees in the Ambea Group. Both programmes correspond essentially to the programmes adopted in 2017 and 2018. For further information about the programmes, see information from the Annual General Meeting at ambea.se/investerare/bolagsstyrning/bolagsstamma/arsstamma-2019
Legal process on social costs for temporary personnel in Norway
Since the first quarter, Ambea, through the acquisition of Aleris's care operations, has been party to an ongoing legal process in Norway regarding social security costs for temporary employees. Ambea's exposure due to this process is limited to NOK 30 million, which has been reserved as a provision in the combined balance sheet after the acquisition. Ambea is working actively to increase the proportion of permanent employees in the Norwegian operations.
Tax audit in Norway
The Norwegian Tax Administration had previously initiated an audit of Aleris's care operations' reporting of tax for temporary employees. The audit continued during the quarter and Ambea is waiting for feedback on the Tax Administration's assessment.
Tax audit in Sweden
In 2018, Ambea received a reassessment notice from the Swedish Tax Agency regarding VAT of SEK 12 million, including tax surcharges, for prior years in Ambea AB (publ). The reassessment was mainly related to VAT on IPO costs in 2017. The company has appealed the Swedish Tax Agency's preliminary decision and is awaiting further assessment in the Administrative Court, which is why no provision has been made for the cost.
Related-party transactions
During the quarter, no transactions took place between Ambea and its related parties that had any material impact on the company's position and earnings. The nature and volume of transactions remained unchanged during the period compared with the preceding year.
Events after the end of the quarter
On 1 July, Ambea's Nytida business area acquired Pusselbiten School, which conducts special needs operations, after-school activities and short-term supervision in Skåne.
Seasonal variations
Ambea's operating profit is affected by seasonal variations, weekends and public holidays.
Weekends and public holidays reduce Ambea's profitability due to higher personnel costs for inconvenient working hours. The first or second quarter is affected by Easter, depending on which quarter the Easter holiday falls, while the first and fourth quarter are affected by Christmas and New Year holidays.
The company's personnel costs are affected in a similar manner when employees take out their holidays. For example, the company is most profitable in the third quarter, as employees typically take their holidays during July and August and therefore receive holiday pay that is accrued continuously throughout the year. Costs during
the summer months are also generally lower due to a reduced schedule for central activities, such as mandatory training programmes and central initiatives, during this period.
Employees
During the quarter, the average number of full-time employees (FTEs) was 12,544 (7,301), and the increase was mainly due to acquisitions.
Parent Company
The Parent Company's earnings pertain to Group-wide costs. During the quarter, Parent Company net sales amounted to SEK 4 million (6). The quarterly results totalled SEK -29 million (0).
The weaker earnings were mainly attributable to increased interest expense due to the acquisition of Aleris's care operations.
Risks and uncertainties
Ambea is exposed to a variety of risks and attaches great importance to continuously analysing, minimising and managing these risks. The risk assessment is also central to the annual strategy process, where risks in relation to the company's ability to achieve its financial targets and strategic ambitions are specifically evaluated. Ambea has identified the following risks: brand risks, industry and market risks, compliance and legal risks, operational risks and financial risks. For a description of these risks and how they are managed, refer to pages 45–47 of the 2018 Annual Report.
Other information
The company's auditors have not reviewed this report.
The Board of Directors' assurance
The Board of Directors and President hereby provide their assurance that this interim report provides a true and fair overview of the operations, position and earnings of the Parent Company and the Group, and describes the material risks and uncertainties facing the Parent Company and the companies in the Group.
Stockholm, 19 August 2019
Lena Hofsberger Chair of the Board
| Daniel Björklund | Anders Borg | Lars Gatenbeck |
|---|---|---|
| Liselott Kilaas | Gunilla Rudebjer | Mikael Stöhr |
| Patricia Briceño Employee representative |
Charalampos Kalpakas Employee representative |
Magnus Sällström Employee representative |
Fredrik Gren President and CEO
Presentation of second quarter of 2019
Ambea will hold a presentation for the financial market, with the possibility to participate by teleconference, at 10:00 a.m. CEST on Tuesday, 20 August 2019. The presentation will be held in English, and be available as a webcast at www.ambea.se.
Call-up information
To make sure that the hook-up to the conference call works, please call at least five minutes before the conference call starts to register.
Phone numbers:
| Sweden: | +46 (0)8 506 921 80 |
|---|---|
| UK: | +44 (0)20 71 92 80 00 |
| US: | +1 63 15 10 74 95 |
Contact
Jacob Persson, Head of Investor Relations, telephone +46 (0)708 64 07 52
Forthcoming report occasions
Report on the third quarter 8 November 2019 Report on the fourth quarter 14 February 2020
Ambea is the leading private care company in Sweden, Norway and Denmark, with more than 900 units and approximately 26,000 employees. Within our group of companies, we provide residential facilities, support, education and social care staffing. We aim to be the quality leader in all that we do and our vision is to make the world a better place, one person at a time. The company was founded in 1996, is headquartered in Solna and listed on Nasdaq Stockholm. ambea.se
Consolidated income statement in summary
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| OPERATING INCOME | ||||||
| Net sales | 2,877 | 1,518 | 5,393 | 2,985 | 8,485 | 6,076 |
| Other operating income | 25 | 17 | 41 | 27 | 84 | 70 |
| Total operating income | 2,902 | 1,535 | 5,434 | 3,012 | 8,569 | 6,146 |
| OPERATING EXPENSES | ||||||
| Consumables | -121 | -45 | -212 | -89 | -307 | -184 |
| Other external costs | -409 | -309 | -786 | -606 | -1,430 | -1,251 |
| Personnel costs | -2,087 | -1,052 | -3,896 | -2,066 | -5,972 | -4,142 |
| Depreciation, amortisation and impairment of tangible and intan gible assets |
-200 | -34 | -394 | -66 | -464 | -135 |
| Profit/loss from participations in Group companies | – | – | – | -4 | – | -4 |
| Other operating expenses | -2 | 0 | -2 | 0 | -3 | -1 |
| Operating expenses | -2,819 | -1,440 | -5,290 | -2,831 | -8,176 | -5,717 |
| OPERATING PROFIT | 83 | 95 | 144 | 181 | 393 | 429 |
| Financial income | 1 | 1 | 13 | 2 | 13 | 2 |
| Financial expenses | -68 | -4 | -129 | -14 | -155 | -40 |
| Net financial items | -67 | -3 | -116 | -12 | -142 | -38 |
| PROFIT AFTER NET FINANCIAL ITEMS | 16 | 92 | 28 | 169 | 251 | 391 |
| PROFIT BEFORE TAX | 16 | 92 | 28 | 169 | 251 | 391 |
| Tax on profit for the period | -4 | -17 | -6 | -34 | -68 | -96 |
| PROFIT FOR THE PERIOD | 12 | 75 | 22 | 135 | 183 | 295 |
| Profit for the period attributable to shareholders of the Parent Company |
12 | 75 | 22 | 135 | 183 | 295 |
| Earnings/loss per share before dilution, SEK | 0.16 | 1.00 | 0.29 | 1.80 | 2.40 | 3.95 |
| Earnings/loss per share after dilution, SEK | 0.16 | 1.00 | 0.29 | 1.80 | 2.40 | 3.94 |
Consolidated statement of comprehensive income in summary
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| PROFIT FOR THE PERIOD AFTER TAX | 12 | 75 | 22 | 135 | 183 | 295 |
| OTHER COMPREHENSIVE INCOME, ITEMS NOT TRANSFERABLE TO PROFIT OR LOSS |
||||||
| Remeasurement of defined-benefit pension plans | – | – | – | – | – | – |
| Tax related to remeasurement of defined-benefit pension plans | – | – | – | – | – | – |
| Total items not transferable to profit or loss | – | – | – | – | – | – |
| OTHER COMPREHENSIVE INCOME, ITEMS TRANSFERABLE TO PROFIT OR LOSS |
||||||
| Translation differences | 13 | 9 | 19 | 23 | 1 | 5 |
| Hedging of net investments in foreign operations | -3 | -8 | -14 | -21 | 2 | -5 |
| Cash flow hedges | 0 | – | 0 | – | 0 | – |
| Hedging cost reserve | -2 | – | -3 | – | –3 | – |
| Tax | 2 | 2 | 4 | 5 | 0 | 1 |
| Total items transferable to profit or loss | 10 | 3 | 6 | 7 | 0 | 1 |
| Total other comprehensive income | 10 | 3 | 6 | 7 | 0 | 1 |
| TOTAL COMPREHENSIVE INCOME FOR THE PERIOD | 22 | 78 | 28 | 142 | 183 | 296 |
| Comprehensive income for the period attributable to share holders of the Parent Company |
22 | 78 | 28 | 142 | 183 | 296 |
Earnings per share
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| Profit for the period attributable to shareholders of the Parent Company, SEK million |
12 | 75 | 22 | 135 | 183 | 295 |
| Earnings per share before dilution | ||||||
| Average number of shares, thousands | 78,919 | 74,873 | 76,833 | 74,873 | 75,776 | 74,798 |
| Earnings/loss per share before dilution, SEK | 0.16 | 1.00 | 0.29 | 1.80 | 2.40 | 3.94 |
| Earnings per share after dilution | ||||||
| Average number of shares, thousands | 79,067 | 74,893 | 76,986 | 74,892 | 75,931 | 74,835 |
| Earnings/loss per share after dilution, SEK | 0.16 | 1.00 | 0.29 | 1.80 | 2.40 | 3.94 |
Consolidated balance sheet in summary
| SEK million | 30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| ASSETS | |||
| Fixed assets | |||
| Goodwill | 6,563 | 4,069 | 4,058 |
| Customer contracts and customer relationships | 648 | 488 | 446 |
| Other intangible assets | 7 | 18 | 22 |
| Right-of-use assets1 | 4,364 | – | – |
| Tangible assets | 251 | 215 | 211 |
| Derivative instruments | 1 | – | 0 |
| Deferred tax assets | 70 | 59 | 35 |
| Non-current receivables | 32 | 26 | 27 |
| Total fixed assets | 11,936 | 4,875 | 4,799 |
| Current assets | |||
| Inventories | 0 | 0 | 0 |
| Accounts receivable | 1,221 | 623 | 622 |
| Other receivables | 104 | 71 | 68 |
| Prepaid expenses and accrued income | 273 | 161 | 167 |
| Cash and cash equivalents | 238 | 80 | 62 |
| Total current assets excluding assets held for sale | 1,836 | 935 | 919 |
| Assets held for sale | 89 | 70 | 74 |
| Total current assets | 1,925 | 1,005 | 993 |
| TOTAL ASSETS | 13,861 | 5,880 | 5,792 |
1 In the previous period, right-of-use assets relating to leased cars were recognised as tangible assets.
Consolidated balance sheet in summary – continuation
| SEK million | 30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| Equity | |||
| Share capital | 2 | 2 | 2 |
| Other capital contributions | 6 167 | 4,965 | 4,965 |
| Reserves | 25 | 7 | 1 |
| Retained earnings including profit or loss for the period | -2 330 | -2,418 | -2,261 |
| Total equity attributable to shareholders of the Parent Company | 3,864 | 2,556 | 2,707 |
| Non-controlling interests | – | – | – |
| Total equity | 3,864 | 2,556 | 2,707 |
| Non-current liabilities | |||
| Non-current interest-bearing liabilities | 2,194 | 616 | 614 |
| Lease liabilities1 | 3,846 | – | – |
| Other non-interest-bearing liabilities | 0 | 0 | 0 |
| Pension provisions | 38 | 6 | 4 |
| Other provisions | 63 | 0 | 0 |
| Deferred tax liabilities | 155 | 121 | 114 |
| Total non-current liabilities | 6,296 | 743 | 732 |
| Current liabilities | |||
| Current interest-bearing liabilities | 0 | 42 | 37 |
| Commercial papers | 1,497 | 1,615 | 1,404 |
| Lease liabilities2 | 549 | – | – |
| Accounts payable | 287 | 183 | 198 |
| Current tax liabilities | 35 | 61 | 93 |
| Other non-interest-bearing liabilities | 168 | 73 | 74 |
| Accrued expenses and deferred income | 1,165 | 607 | 547 |
| Total current liabilities | 3,701 | 2,581 | 2,353 |
| TOTAL EQUITY AND LIABILITIES | 13,861 | 5,880 | 5,792 |
Consolidated statement of changes in equity in summary
| SEK million | 2019 Jan–Jun |
2018 Jan–Jun |
2018 Jan–Dec |
|||
|---|---|---|---|---|---|---|
| Opening balance | 2,707 | 2,480 | 2,480 | |||
| Total comprehensive income | 28 | 142 | 296 | |||
| Transactions with shareholders | ||||||
| Warrants issued | – | 2 | 3 | |||
| Share buybacks | – | – | -4 | |||
| New share issue | 1,220 | – | – | |||
| Issue expenses | -17 | – | – | |||
| Dividends | -74 | -68 | -68 | |||
| Closing balance | 3,864 | 2,556 | 2,707 |
1 In the previous period, lease liabilities relating to leased cars were recognised as non-current interest-bearing liabilities.
2 In the previous period, lease liabilities relating to leased cars were recognised as current interest-bearing liabilities.
Consolidated cash flow statement in summary
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| OPERATING ACTIVITIES | ||||||
| Profit before tax | 16 | 92 | 28 | 169 | 250 | 391 |
| Adjustment for non-cash items | 185 | 34 | 400 | 71 | 462 | 134 |
| Cash flow from operating activities before working capital and tax |
201 | 126 | 428 | 240 | 712 | 525 |
| Tax paid | -30 | -6 | -97 | -43 | -114 | -60 |
| Cash flow from operating activities before changes in work ing capital |
171 | 120 | 331 | 197 | 599 | 465 |
| CASH FLOW FROM CHANGES IN WORKING CAPITAL | ||||||
| Change in operating receivables | -64 | 54 | -132 | 44 | -142 | 36 |
| Change in operating liabilities | 110 | 74 | 73 | 77 | 34 | 37 |
| Cash flow from operating activities | 218 | 247 | 272 | 318 | 491 | 538 |
| INVESTING ACTIVITIES | ||||||
| Investment in intangible assets | 0 | -2 | -4 | -2 | -3 | -1 |
| Investment in tangible assets | -40 | -9 | -67 | -18 | -87 | -38 |
| Divestment of tangible assets | 1 | – | 11 | 4 | 14 | 7 |
| Free cash flow | 178 | 236 | 212 | 302 | 414 | 506 |
| Acquisition and disposal of shares and participations | 6 | -296 | -2,587 | -349 | -2,605 | -368 |
| Other financial assets | 4 | 0 | -3 | 0 | -3 | 0 |
| Cash flow from investing activities | -31 | -307 | -2,650 | -365 | -2,684 | -400 |
| Cash flow after investing activities | 187 | -60 | -2,378 | -47 | -2,193 | 139 |
| FINANCING ACTIVITIES | ||||||
| New loans/Loans raised | 1,421 | -105 | 6,357 | 262 | 6,445 | 1,399 |
| Repayment of loan liabilities | -2,549 | -8 | -3,654 | -28 | -3,982 | -1,405 |
| Repayment of lease liability | -121 | – | -256 | – | -256 | – |
| Change in revolving credit facility | -126 | 244 | -1,018 | -118 | -989 | -89 |
| New share issue | 1,202 | – | 1,202 | – | 1,203 | 1 |
| Premiums for warrants | – | 2 | – | 2 | 0 | 2 |
| Share buybacks | – | – | – | – | -4 | -4 |
| Dividends paid | -74 | -68 | -74 | -68 | -74 | -68 |
| Cash flow from financing activities | -247 | 67 | 2,558 | 51 | 2,344 | -164 |
| CASH FLOW DURING THE PERIOD | -60 | 7 | 180 | 4 | 151 | -25 |
| Cash and cash equivalents on the opening date | 297 | 77 | 62 | 87 | 80 | 87 |
| Exchange rate differences in cash and cash equivalents | 0 | -4 | -4 | -11 | 7 | 0 |
| Cash and cash equivalents on the closing date | 238 | 80 | 238 | 80 | 238 | 62 |
Parent Company income statement in summary
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Net sales | 4 | 6 | 9 | 11 | 27 | 29 |
| Total income | 4 | 6 | 9 | 11 | 27 | 29 |
| OPERATING EXPENSES | ||||||
| Other external costs | -2 | -5 | -8 | -11 | -17 | -22 |
| Personnel costs | -6 | -6 | -10 | -11 | -24 | -25 |
| Amortisation of intangible assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating expenses | -8 | -11 | -18 | -22 | -42 | -47 |
| OPERATING PROFIT | -4 | -5 | -9 | -11 | -15 | -18 |
| Financial items | -25 | 5 | -49 | 6 | -53 | 2 |
| LOSS AFTER FINANCIAL ITEMS | -29 | 0 | -57 | -5 | -68 | -16 |
| Appropriations | – | – | – | – | 15 | 15 |
| PROFIT/LOSS BEFORE TAX | -29 | 0 | -57 | -5 | -53 | -1 |
| Tax on profit for the period | – | – | – | – | – | |
| PROFIT/LOSS FOR THE PERIOD | -29 | 0 | -57 | -5 | -53 | -1 |
Parent Company balance sheet in summary
| SEK million | 30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| ASSETS | |||
| Intangible assets | |||
| Software | 1 | 1 | 1 |
| Financial assets | |||
| Participations in Group companies | 7,206 | 4,128 | 4,129 |
| Other financial assets | – | 32 | |
| Derivative assets | 4 | – | – |
| Total fixed assets | 7,212 | 4,129 | 4,162 |
| Current assets | |||
| Receivables from Group companies | 28 | 55 | 23 |
| Other receivables | 18 | 4 | 16 |
| Tax assets | 5 | 2 | 2 |
| Prepaid expenses and accrued income | 9 | 6 | 4 |
| Cash and bank balances | 0 | 9 | 0 |
| Total current assets | 60 | 76 | 45 |
| TOTAL ASSETS | 7,272 | 4,205 | 4,207 |
| EQUITY AND LIABILITIES | |||
| Share capital | 2 | 2 | 2 |
| Statutory reserve | 0 | 0 | 0 |
| Total restricted equity | 3 | 2 | 2 |
| Share premium reserve | 1,402 | 200 | 200 |
| Retained earnings | 1,776 | 1,856 | 1,852 |
| Loss for the period | -58 | -5 | -1 |
| Total non-restricted equity | 3,121 | 2,051 | 2,051 |
| TOTAL EQUITY | 3,123 | 2,053 | 2,053 |
| Non-current liabilities | |||
| Liabilities to credit institutions | 2,619 | 522 | 713 |
| Current liabilities | |||
| Commercial papers | 1,479 | 1,615 | 1,404 |
| Accounts payable | 16 | 5 | 7 |
| Other liabilities | 0 | 0 | 2 |
| Accrued expenses and deferred income | 15 | 10 | 28 |
| Total current liabilities | 1,529 | 1,630 | 1,441 |
| TOTAL EQUITY AND LIABILITIES | 7,272 | 4,205 | 4,207 |
Key financial figures
| SEK million | 2019 Apr–Jun |
2019 Apr–Jun excl IFRS 16 |
2018 Apr–Jun |
% | 2019 Jan–Jun |
2018 Jan–Jun |
% | 2018/2019 Rolling 12 months |
2018 Jan–Dec |
% |
|---|---|---|---|---|---|---|---|---|---|---|
| Net sales | 2,877 | 2,877 | 1,518 | 90 | 5,393 | 2,985 | 81 | 8,485 | 6,076 | 40 |
| Growth in net sales (%) | 90 | 90 | 5 | 81 | 4 | 40 | 4 | |||
| EBITDA | 283 | 113 | 129 | 119 | 538 | 247 | 118 | 857 | 564 | 52 |
| Operating margin, EBITDA (%) | 9.8 | 3.9 | 8.5 | 10.0 | 8.3 | 10.1 | 9.3 | |||
| Items affecting comparability | 57 | 57 | - | 114 | 149 | 39 | ||||
| Adjusted EBITDA | 340 | 170 | 129 | 164 | 652 | 251 | 160 | 1,006 | 603 | 67 |
| Operating margin, adjusted EBITDA (%) | 11.8 | 5.9 | 8.5 | 12.1 | 8.4 | 11.9 | 9.9 | |||
| EBITA | 118 | 94 | 114 | 4 | 209 | 218 | -5 | 499 | 508 | -2 |
| Operating margin, EBITA (%) | 4.1 | 3.3 | 7.5 | 3.9 | 7.3 | 5.9 | 8.4 | |||
| Adjusted EBITA | 175 | 151 | 114 | 54 | 323 | 222 | 45 | 648 | 547 | 18 |
| Operating margin, adjusted EBITA (%) | 6.1 | 5.3 | 7.5 | 6.0 | 7.4 | 7.6 | 9.0 | |||
| Operating profit/loss, EBIT | 83 | 59 | 95 | -13 | 144 | 181 | -20 | 393 | 429 | -8 |
| Operating margin, EBIT (%) | 2.9 | 2.1 | 6.3 | 2.7 | 6.1 | 4.6 | 7.1 | |||
| Profit before tax | 16 | 30 | 92 | -83 | 28 | 169 | -83 | 251 | 391 | -36 |
| Profit after tax | 12 | 23 | 75 | -84 | 22 | 135 | -82 | 183 | 295 | -38 |
| Earnings/loss per share before dilution, SEK |
0.16 | 0.29 | 1.00 | -84 | 0.29 | 1.80 | -84 | 2.40 | 3.95 | -39 |
| Earnings/loss per share after dilution, SEK |
0.16 | 0.29 | 1.00 | -84 | 0.29 | 1.80 | -84 | 2.40 | 3.94 | -39 |
| Return on equity (%) | 0.4 | 0.7 | 2.9 | -88 | 0.7 | 5.8 | -83 | 5.7 | 11.4 | -45 |
| Operating cash flow | 338 | 168 | 248 | 38 | 550 | 366 | 49 | 831 | 609 | 28 |
| Free cash flow | 178 | 46 | 236 | -25 | 212 | 302 | -30 | 414 | 506 | -18 |
| Cash conversion (%) | 99.4 | 98.8 | 192.2 | -48 | 84.4 | 145.8 | -43 | 82.6 | 107.5 |
Notes
Note 1 Accounting policies
This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Swedish Annual Accounts Act, as well as the Swedish Financial Reporting Board's RFR 1, Supplementary Accounting Rules for Groups, and RFR 2 Accounting for Legal Entities. The accounting policies applied are consistent with those applied in the preparation of the most recent annual report, except for hedge accounting. Hedge accounting in accordance with IFRS 9 was applied to the hedge agreement signed in March 2019. Hedge accounting in accordance with IFRS 9 is applied as of 1 January 2019. Existing hedge relationships in accordance with IAS 39 meet the criteria for continued hedge accounting in accordance with IFRS 9, and no effects arose as a result of the transition.
New or revised IFRS standards
IFRS 16 Leases took effect on 1 January 2019 and supersedes the previous IFRS related to lease accounting. For a more detailed description of accounting policies, refer to Note G1 in the 2018 Annual Report.
Selection of method and exceptions
Ambea has chosen to apply the simplified transitional approach, which requires a restatement on the transition date by adjusting the opening balance at 1 January 2019. Ambea has
also elected to apply the transition relief that excludes shortterm leases and leases of low-value.
Discounting
For contracts with terms of up to 3 years, the marginal lending rate is 1.75 per cent. For contracts with terms of 3 years or more, Ambea has assumed a risk-free interest rate corresponding to STIBOR and the equivalent for Norway, and added a margin of 1.75 per cent.
Transition effects, IFRS 16
Given that the transition to IFRS 16 will have a material impact on the financial statements, Ambea has elected to recognise a reconciliation between its commitments for operating leases at the end of 2018 and its lease liability at the start of 2019.
In Note G1 in the 2018 Annual Report and in this interim report, selected key figures are presented without the effects of IFRS 16. For definitions, refer to Note 9, and for reconciliation with IFRS financial statements, refer to Note 8.
Earnings per share
Due to the new issue conducted, the comparative figures for earnings per share were restated to reflect the bonus issue element.
Reconciliation of operating lease capitalisation
| SEK million | Group |
|---|---|
| Obligations for operating leases excl. extension options at 1 January 2019 | 3,730 |
| Extension options | 142 |
| Liabilities for finance leases at 1 January 2019 | 39 |
| Discounting with the Group's weighted average incremental borrowing rate | -671 |
| Short-term leases | -36 |
| Right-of-use assets recognised at 1 January 2019 | 3,204 |
Note 2 Key judgements and estimates
For information about key judgements and estimates in this interim report, refer to Note G32 in the company's 2018 Annual Report.
Note 3 Segment information
Due to the acquisition of Aleris's care operations, a segment comprising the Danish operations has been added. The name of the Norwegian operations has now been changed from Heimta to Stendi, and also includes the operations acquired from Aleris.
Vardaga Comprises elderly care in Sweden.
- Nytida Comprises care for people with functional disabilities in Sweden.
- Stendi Comprises support for children and young people, personal assistance, residential care, elderly care and home care in Norway.
- Altiden Comprises elderly care, home care, social care and disability care in Denmark.
- Klara Comprises staffing solutions, such as the supply of temporary doctors, nurses and other care workers, in Sweden.
Segments
| Apr–Jun 2019 SEK million |
Vardaga | Nytida | Stendi | Altiden | Klara | Unallocated items1 |
Group adjust ments |
Group |
|---|---|---|---|---|---|---|---|---|
| OPERATING INCOME | ||||||||
| Net sales | 879 | 940 | 853 | 129 | 76 | – | – | 2,877 |
| Other operating income | 5 | 5 | 11 | – | 11 | 4 | -11 | 25 |
| Internal transactions | – | – | – | – | -11 | 11 | – | |
| Total income from external customers | 884 | 945 | 864 | 129 | 76 | 4 | – | 2,902 |
| EBITA | 34 | 115 | 10 | -5 | 6 | -43 | – | 118 |
| EBITA margin, % | 3.9 | 12.2 | 1.2 | -3.9 | 7.9 | – | 4.1 | |
| Items affecting comparability | – | – | – | - | – | 57 | – | 57 |
| Adjusted EBITA | 34 | 115 | 10 | -5 | 6 | 14 | – | 175 |
| Adjusted EBITA margin, % | 3.9 | 12.2 | 1.2 | -3.9 | 7.9 | – | 6.1 | |
| Amortisation of intangible assets | -35 | |||||||
| Operating profit (EBIT) | 83 | |||||||
| Net financial items | -66 | |||||||
| Profit after net financial items | 16 | |||||||
| Profit before tax | 16 | |||||||
| Tax on profit for the period | -4 | |||||||
| PROFIT FOR THE PERIOD | 12 | |||||||
| ASSETS | 4,335 | 6,140 | 2,581 | 241 | 182 | 382 | – | 13,861 |
| Apr–Jun 2018 SEK million |
Vardaga | Nytida | Stendi | Altiden | Klara | Unallocated items1 |
Group adjust ments |
Group |
|---|---|---|---|---|---|---|---|---|
| OPERATING INCOME | ||||||||
| Net sales | 556 | 747 | 131 | – | 83 | – | – | 1,518 |
| Other operating income | 7 | 5 | 2 | – | 9 | 3 | -9 | 17 |
| Internal transactions | – | – | – | – | -9 | – | 9 | – |
| Total income from external customers | 563 | 752 | 133 | – | 83 | 3 | – | 1,535 |
| EBITA | 33 | 80 | 6 | – | 4 | -10 | – | 114 |
| EBITA margin, % | 5.9 | 10.7 | 4.6 | – | 4.8 | – | – | 7.5 |
| Items affecting comparability | – | – | – | – | – | – | – | – |
| Adjusted EBITA | 33 | 80 | 6 | – | 4 | -10 | – | 114 |
| Adjusted EBITA margin, % | 5.9 | 10.7 | 4.6 | – | 4.8 | – | – | 7.5 |
| Amortisation of intangible assets | -19 | |||||||
| Operating profit (EBIT) | 95 | |||||||
| Net financial items | -3 | |||||||
| Profit after net financial items | 92 | |||||||
| Profit before tax | 92 | |||||||
| Tax on profit for the period | -17 | |||||||
| PROFIT FOR THE PERIOD | 75 | |||||||
| ASSETS | 1,372 | 3,640 | 546 | – | 181 | 141 | – | 5,880 |
1 The "Unallocated items" column consists of centrally approved costs for general cen-
tral administration, restructures and acquisitions and for IPO costs.
Segments
| January–June 2019 SEK million |
Vardaga | Nytida | Stendi | Altiden | Klara | Unallocated items1 |
Group adjust ments |
Group |
|---|---|---|---|---|---|---|---|---|
| OPERATING INCOME | ||||||||
| Net sales | 1,675 | 1,813 | 1,524 | 226 | 155 | – | – | 5,393 |
| Other operating income | 8 | 8 | 17 | – | 21 | 8 | -21 | 41 |
| Internal transactions | – | – | – | – | -21 | – | 21 | – |
| Total income from external customers | 1,683 | 1,821 | 1,541 | 226 | 155 | 8 | – | 5,434 |
| EBITA | 86 | 218 | -9 | -5 | 11 | -92 | 209 | |
| EBITA margin, % | 5.1 | 12 | – | – | 7.1 | – | – | 3.9 |
| Items affecting comparability | – | – | – | – | – | 114 | – | 114 |
| Adjusted EBITA | 86 | 218 | -9 | -5 | 11 | 22 | – | 323 |
| Adjusted EBITA margin, % | 5.1 | 12.0 | -0.6 | -2.2 | 7.1 | – | – | 6.0 |
| Amortisation of intangible assets | -64 | |||||||
| Operating profit (EBIT) | 144 | |||||||
| Net financial items | -116 | |||||||
| Profit after net financial items | 28 | |||||||
| Profit before tax | 28 | |||||||
| Tax on profit for the period | -6 | |||||||
| PROFIT FOR THE PERIOD | 22 | |||||||
| ASSETS | 4,335 | 6,140 | 2,581 | 241 | 182 | 382 | – | 13,861 |
| January–June 2018 SEK million |
Vardaga | Nytida | Stendi | Altiden | Klara | Unallocated items1 |
Group adjust ments |
Group |
|---|---|---|---|---|---|---|---|---|
| OPERATING INCOME | ||||||||
| Net sales | 1,107 | 1,464 | 253 | – | 161 | – | – | 2,985 |
| Other operating income | 11 | 7 | 3 | – | 17 | 6 | -9 | 27 |
| Internal transactions | – | – | – | – | -17 | – | 9 | – |
| Total income from external customers | 1,118 | 1,471 | 256 | – | 161 | 6 | – | 3,012 |
| EBITA | 68 | 156 | 9 | – | 7 | -23 | – | 218 |
| EBITA margin, % | 6.1 | 10.7 | 3.6 | – | 4.3 | – | – | 7.3 |
| Items affecting comparability | – | – | – | – | – | 4 | – | 4 |
| Adjusted EBITA | 68 | 156 | 9 | – | 7 | -19 | – | 222 |
| Adjusted EBITA margin, % | 6.1 | 10.7 | 3.6 | – | 4.3 | – | – | 7.4 |
| Amortisation of intangible assets | -37 | |||||||
| Operating profit (EBIT) | 181 | |||||||
| Net financial items | -12 | |||||||
| Profit after net financial items | 169 | |||||||
| Profit before tax | 169 | |||||||
| Tax on profit for the period | -34 | |||||||
| PROFIT FOR THE PERIOD | 135 | |||||||
| ASSETS | 1,372 | 3,640 | 546 | – | 181 | 141 | – | 5,880 |
1 The "Unallocated items" column consists of centrally approved costs for general cen-
tral administration, restructures and acquisitions and for IPO costs.
Note 4 Income
| Jan-Jun | Vardaga | Nytida | Stendi | Altiden | Klara | Group | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 |
| Own Management | 971 | 550 | 1,578 | 1,217 | 1,321 | 178 | 26 | – | – | – | 3,896 | 1,809 |
| Contract Management | 704 | 557 | 235 | 247 | 203 | – | 200 | – | – | – | 1,342 | 893 |
| Staffing | – | – | – | – | – | – | – | – | 155 | 162 | 155 | 162 |
| Total | 1,675 | 1,107 | 1,813 | 1,464 | 1,524 | 178 | 226 | – | 155 | 162 | 5,393 | 2,864 |
Note 5 Preliminary effects of the acquisition of Aleris's care operations
On 16 October 2018, it was announced that Ambea had agreed to acquire Aleris Omsorg. Aleris Omsorg conducts care operations in Sweden, Norway and Denmark. Ambea acquired 100 per cent of the shares in the Parent Company, Aleris Care AB, on 21 January 2019, following approval from the relevant competition authorities, for a purchase price of approximately SEK 2,600 million on a debt-free, cash-free basis at the transfer date. The acquisition makes Ambea the largest care services provider in Scandinavia. The acquisition of Aleris Omsorg is creating a stable platform for future organic growth and significant potential for both direct cost synergies and operational improvements. In addition to direct cost synergies of SEK 90 million and identified operational improvements of SEK 30 million, Ambea expects that additional efficiencies can be realised over the next two to three years.
The acquisition was recognised using the acquisition method, and Aleris's Care Operations have been included in the financial statements for the Ambea Group since 21 January 2019.
Acquired receivables mainly comprise accounts receivable. As these are expected to be paid, in all material respects, the fair value is consistent with the carrying amount. Aleris's customers are predominantly municipalities, whereby credit risk is deemed low.
In the acquisition calculation, adjustments were made on the provisions line, since additional reserve requirements were identified, of which the majority pertain to disputes related to the legal process regarding social security costs for temporary employees in Norway.
Acquired lease liabilities have been measured at the present value of the remaining lease payments (as defined in IFRS 16) as if the acquired lease was new at the acquisition date. Calculations have been made using the same methodology and assumptions as when the effects of IFRS 16 were calculated for Ambea, and are presented in Note G6 in the 2018 Annual Report. At the acquisition date, right-of-use assets have been measured at the same amount as lease liabilities.
Goodwill arising is primarily attributable to human capital, the pipeline under Own Management, a stronger market position and expected synergies. The expected direct cost synergies amount to SEK 90 million annually, of which half are expected to be realised in 2019 and the remainder in 2020. Identified operational improvements are expected to amount to SEK 30 million annually, and estimated to be realised in 2020. Integration costs related to the acquisition are an estimated SEK 100 million, most of which are expected to be recognised in 2019.
Since the acquisition date, Aleris Omsorg has contributed SEK 2,308 million to net sales and SEK 0 million to profit before tax. If the acquisition had taken place on 1 January 2019, Aleris Omsorg would have contributed SEK 2,583 million to net sales and SEK -3 million to profit before tax.
In June 2019, negotiations were completed on the transfer balance with Aleris, whereby Aleris compensated Ambea with SEK 5.6 million and interest.
Net assets of Aleris's care operations at the acquisition date
| SEK million | Fair value recognised in the Group |
|---|---|
| Tangible assets | 100 |
| Intangible assets1 | 260 |
| Financial assets | 32 |
| Right-of-use assets | 1,268 |
| Accounts receivable and other receivables | 605 |
| Cash and cash equivalents | 455 |
| Non-current interest-bearing liabilities | 2 |
| Deferred tax liability | 41 |
| Pension provisions | 26 |
| Other provisions | 73 |
| Lease liabilities | 1,268 |
| Accounts payable and other liabilities | 735 |
| Net identifiable assets and liabilities | 575 |
| Group goodwill | 2,475 |
| Price of shares | 3,050 |
| Cash (acquired) | 455 |
| Purchase consideration (net cash outflow) | 2,594 |
| Change in the Group's goodwill | |
| Opening balance, 1 January 2019 | 4,058 |
| Acquisition of Aleris Omsorg | 2,475 |
| Translation difference | 30 |
| Closing cumulative cost | 6,563 |
1 The acquisition analysis is preliminary. The measurement of intangible assets and their related amortisation period had not ended when the financial statements were published for the second quarter of 2019. The value of intangible assets may therefore be adjusted in a future period, with a corresponding adjustment of goodwill.
Note 6 Fair value of financial instruments in the fair value hierarchy
Ambea applies the following hierarchy for the measurement of financial instruments at fair value:
Level 1 – Quoted prices (unadjusted) in active markets for identical assets or liabilities. This level includes Eligible treasury bills, Bonds and Other interest-bearing securities. Remeasurement is recognised under Financial items.
Level 2 – Observable data for assets or liabilities other than quoted prices included in Level 1, either directly (i.e. as price quotations) or indirectly (i.e. derived from price quotations). This level includes derivative instruments that are recognised under Other current assets or Other current liabilities.
Level 3 – Data for assets or liabilities not based on observable market data.
Ambea has credit/loans denominated in both SEK and NOK and is thereby exposed to interest-rate risk. According to the company's financial policy, at least 50 per cent of the interest-rate risk should be hedged. To reduce the company's interest-rate risk, the company purchased an interest-rate swap and an interest rate cap in March 2019, both with maturities of three years. In total, 54 per cent of the company's interest-rate risk is hedged through interest-rate derivatives.
Derivatives are classified as Level 2 assets in the fair value hierarchy. The change in fair value of the interest rate cap is recognised in other comprehensive income and SEK 2 million was charged against other comprehensive income for the quarter. At 30 June 2019, the value of the derivatives was SEK 1 million. Ambea uses the standard report of issuing banks for the market valuation of purchased interest-rate caps. The measurement is based on the bank's standard pricing model and method. The measurement is based on the bank's average price.
Consolidated assets and liabilities measured at fair value
| SEK million | 30 Jun | 30 Jun | 31 Dec |
|---|---|---|---|
| 2019 | 2018 | 2018 | |
| Interest rate derivatives | 1 | 0 | 0 |
Note 7 Pledged assets and contingent liabilities
| SEK million | 30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| Leased assets | 81 | 86 | 80 |
| Chattel mortgages | 7 | 13 | 10 |
| Real estate mortgages | 9 | 23 | 9 |
| Factoring | 2 | 2 | 2 |
| Total pledged assets | 99 | 124 | 101 |
Contingent liabilities
The Group is sometimes involved in lawsuits and legal proceedings that are related to day-to-day business activities. The claims relate to, but are not limited to, the Group's business practices, personnel matters and tax issues. With respect to matters that do not require any provisions, the Group, based on information that is currently available, is of the opinion that these will not result in any significantly negative effects on the Group's financial results.
Note 8 Reconciliation with IFRS financial statements
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| Growth/Acquired growth | ||||||
| Growth in net sales (%) | 90 | 5 | 81 | 4 | 40 | 4 |
| Of which acquired growth (%) | 88 | 8 | 79 | 8 | 42 | 5 |
| Of which currency effect (%) | 0 | 0 | 0 | 0 | 0 | 0 |
| Of which organic growth (%) | 1 | -3 | 2 | -4 | 1 | -1 |
| Operating margin (EBIT) | ||||||
| Net sales | 2,877 | 1,518 | 5,393 | 2,985 | 8,485 | 6,076 |
| Operating profit (EBIT) | 83 | 95 | 144 | 181 | 393 | 429 |
| Operating margin, EBIT (%) | 2.9 | 6.3 | 2.7 | 6.1 | 4.6 | 7.1 |
| EBITA and adjusted EBITA | ||||||
| Operating profit (EBIT) | 83 | 95 | 144 | 181 | 393 | 429 |
| Amortisation and impairment of intangible assets | 35 | 19 | 65 | 37 | 106 | 79 |
| EBITA | 118 | 114 | 209 | 218 | 499 | 508 |
| Items affecting comparability | 57 | – | 114 | 4 | 149 | 39 |
| Adjusted EBITA | 175 | 114 | 323 | 222 | 648 | 547 |
| Net sales | 2,877 | 1,518 | 5,393 | 2,985 | 8,485 | 6,076 |
| EBITA margin (%) | 4.1 | 7.5 | 3.9 | 7.3 | 5.9 | 8.4 |
| Adjusted EBITA margin (%) | 6.1 | 7.5 | 6.0 | 7.4 | 7.6 | 9.0 |
| EBITDA and adjusted EBITDA | ||||||
| Operating profit (EBIT) | 83 | 95 | 144 | 181 | 393 | 429 |
| Depreciation, amortisation and impairment of tangible and intangible assets |
200 | 34 | 394 | 66 | 464 | 135 |
| EBITDA | 283 | 129 | 538 | 247 | 857 | 564 |
| Items affecting comparability | 57 | – | 114 | 4 | 149 | 39 |
| Adjusted EBITDA | 340 | 129 | 652 | 251 | 1,006 | 603 |
| Net sales | 2,877 | 1,518 | 5,393 | 2,985 | 8,485 | 6,076 |
| EBITDA margin | 9.8 | 8.5 | 10.0 | 8.3 | 10.1 | 9.3 |
| Adjusted EBITDA margin | 11.8 | 8.5 | 12.1 | 8.4 | 11.9 | 9.9 |
| EBITDA and adjusted EBITDA excluding IFRS 16 | ||||||
| Operating profit (EBIT) | 83 | n/a | 144 | n/a | 393 | n/a |
| Depreciation, amortisation and impairment of tangible and intangible assets |
200 | n/a | 394 | n/a | 464 | n/a |
| Additional: Rental expenses | -170 | n/a | -329 | n/a | -329 | n/a |
| Net effect of IFRS 16 on EBITDA | -170 | n/a | -329 | n/a | -329 | n/a |
| EBITDA excluding effects of IFRS 16 | 113 | n/a | 209 | n/a | 528 | n/a |
| Items affecting comparability | 57 | n/a | 114 | n/a | 149 | n/a |
| Adjusted EBITDA excluding IFRS 16 | 170 | n/a | 323 | n/a | 677 | n/a |
| SEK million | 2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating cash flow | ||||||
| Adjusted EBITDA | 340 | 129 | 652 | 251 | 1,006 | 603 |
| Adjustment for non-cash items | -19 | -1 | -2 | 3 | -10 | -5 |
| Cash flow from investing activities excl. acquisitions and divestments of subsidiaries |
-40 | -11 | -60 | -16 | -77 | -32 |
| Adjustment for cash flow from investing activities related to in creased capacity/growth |
10 | 3 | 19 | 7 | 21 | 9 |
| Changes in working capital | 47 | 128 | -59 | 121 | -107 | 73 |
| Operating cash flow | 338 | 248 | 550 | 366 | 831 | 648 |
| Cash conversion (%) | ||||||
| Operating cash flow | 338 | 248 | 550 | 366 | 831 | 648 |
| Adjusted EBITDA | 340 | 129 | 652 | 251 | 1,006 | 603 |
| Cash conversion (%) | 99.4 | 192.2 | 84.4 | 145.8 | 82.6 | 107.5 |
| Items affecting comparability | ||||||
| Reversal of restructuring and acquisition-related costs | 57 | – | 114 | – | 149 | 35 |
| – of which costs included in the line item of consumables | 2 | – | 2 | – | 2 | – |
| – of which costs included in the line item of other external costs |
26 | – | 62 | – | 96 | 34 |
| – of which costs included in the line item of personnel costs | 29 | – | 50 | 51 | 1 | |
| Reversal of income and costs for discontinuation of entire seg ments |
– | – | – | 4 | – | 4 |
| Personal assistance | ||||||
| – of which, income | – | – | – | – | – | – |
| – of which costs included in the line item of other external costs |
– | – | – | – | – | – |
| – of which costs included in the line item of personnel costs | – | – | – | – | – | – |
| – of which, profit or loss from participations in Group companies | – | – | – | 4 | – | 4 |
| Total items affecting comparability | 57 | – | 114 | 4 | 149 | 39 |
| Debt/equity ratio SEK million |
30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| Non-current interest-bearing liabilities | 6,040 | 616 | 614 |
| Current interest-bearing liabilities | 2,046 | 1,657 | 1,441 |
| Total interest-bearing liabilities | 8,086 | 2,273 | 2,055 |
| Total equity | 3,864 | 2,556 | 2,707 |
| Debt/equity ratio | 2.1 | 0.9 | 0.8 |
| Net debt, net debt/Adjusted EBITDA, RTM SEK million |
30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| Non-current interest-bearing liabilities | 6,040 | 616 | 614 |
| Current interest-bearing liabilities | 2,046 | 1,657 | 1,441 |
| Less: cash and cash equivalents | -238 | -80 | -62 |
| Net debt | 7,848 | 2,193 | 1,993 |
| Adjusted EBITDA, RTM | 1,006 | 556 | 603 |
| Net debt/Adjusted EBITDA, RTM | 7.8 | 4.0 | 3.3 |
| Equity/assets ratio SEK million |
30 Jun 2019 |
30 Jun 2018 |
31 Dec 2018 |
|---|---|---|---|
| Total equity | 3,864 | 2,556 | 2,707 |
| Total assets | 13,853 | 5,880 | 5,762 |
| Equity/assets ratio (%) | 27.8 | 43.5 | 46.7 |
| Return on equity SEK million |
2019 Apr–Jun |
2018 Apr–Jun |
2019 Jan–Jun |
2018 Jan–Jun |
2018/2019 Rolling 12 months |
2018 Jan–Dec |
|---|---|---|---|---|---|---|
| Opening equity attributable to shareholders of the Parent Company |
2,721 | 2,544 | 2,707 | 2,480 | 2,556 | 2,480 |
| Closing equity attributable to shareholders of the Parent Com pany |
3,864 | 2,556 | 3,864 | 2,556 | 3,864 | 2,707 |
| Average equity attributable to shareholders of the Parent Company |
3,293 | 2,550 | 3,286 | 2,518 | 3,210 | 2,594 |
| Profit after tax | 12 | 75 | 22 | 135 | 183 | 295 |
| Return on equity (%) | 0.4 | 2.9 | 0.7 | 5.4 | 5.7 | 11.4 |
| Profit before and after tax excluding effects of IFRS 16 SEK million |
2019 | |
|---|---|---|
| Jan–Jun | ||
| Profit before tax | 16 | 28 |
| Net effects of IFRS 16 on EBIT | -24 | -42 |
| Less: IFRS 16 effect included in the line item of Financial expenses | 38 | 73 |
| Net effects of IFRS 16 on profit before tax | 14 | 31 |
| Profit before tax excluding effects of IFRS 16 | 30 | 59 |
| Tax on profit for the period | -4 | -6 |
| Less: Effects of IFRS 16 on Deferred tax | -3 | -7 |
| Profit after tax excluding effects of IFRS 16 | 23 | 46 |
| Earnings per share before dilution, excluding effects of IFRS 16 | ||
| Number of shares (000s) | 78,919 | 78,919 |
| Earnings per share before dilution, excluding effects of IFRS 16 | 0.29 | 0.59 |
| Earnings per share after dilution, excluding effects of IFRS 16 | ||
| Number of shares (000s) | 79,067 | 79,067 |
| Earnings per share before dilution, excluding effects of IFRS 16 | 0.29 | 0.59 |
| Operating cash flow excluding IFRS 16 SEK million |
2019 Apr–Jun |
2019 Jan–Jun |
|---|---|---|
| Operating cash flow | 338 | 550 |
| Less: Effect of IFRS 16 on EBITDA | -170 | -329 |
| Operating cash flow excluding IFRS 16 | 168 | 221 |
| Net sales | 2,877 | 5,393 |
| EBITDA margin excluding effects of IFRS 16 | 3.9 | 3.9 |
| Adjusted EBITDA margin excluding effects of IFRS 16 | 5.9 | 6.0 |
| Operating profit (EBIT) excluding effects of IFRS 16 |
2019 Apr–Jun |
2019 Jan–Jun |
|---|---|---|
| Operating profit (EBIT) | 83 | 144 |
| Less: Effects of IFRS 16 included in the line item of depreciation, amortisation and impairment of tangible and intangible assets |
146 | 287 |
| Additional: Rental expenses | -170 | -329 |
| Net effects of IFRS 16 on EBIT | -24 | -42 |
| EBIT excluding effects of IFRS 16 | 59 | 102 |
| EBITA and adjusted EBITA excluding effects of IFRS 16 | ||
| Operating profit (EBIT) | 83 | 144 |
| Amortisation and impairment of intangible assets | 35 | 65 |
| Less: Effects of IFRS 16 included in the line item of depreciation, amortisation and impairment of tangible and intangible assets |
146 | 287 |
| Additional: Rental expenses | -170 | -329 |
| Net effects of IFRS 16 on EBITA | -24 | -42 |
| EBITA excluding effects of IFRS 16 | 94 | 167 |
| Items affecting comparability | 57 | 114 |
| Adjusted EBITA excluding effects of IFRS 16 | 151 | 281 |
| Net sales | 2,877 | 5,393 |
| EBITA margin excluding effects of IFRS 16 (%) | 3.3 | 3.1 |
| Adjusted EBITA margin excluding effects of IFRS 16 (%) | 5.3 | 5.2 |
| Cash conversion excluding IFRS 16 SEK million |
2019 Apr–Jun |
2019 Jan–Jun |
|---|---|---|
| Operating cash flow excluding effects of IFRS 16 | 168 | 221 |
| Adjusted EBITDA excluding effects of IFRS 16 | 170 | 323 |
| Cash conversion (%) excluding IFRS 16 | 98.8 | 68.4 |
| Free cash flow excluding effects of IFRS 16 SEK million |
2019 Apr–Jun |
2019 Jan–Jun |
|---|---|---|
| Free cash flow | 178 | 212 |
| Less: Effect of IFRS 16 on EBITDA | -170 | -329 |
| Change in prepaid rents recognised as an item of operating receivables | -1 | -1 |
| Additional: Interest payments | 73 | |
| Free cash flow excluding effects of IFRS 16 | -45 |
| Return on equity, excluding effects of IFRS 16 SEK million |
2019 | |
|---|---|---|
| Jan–Jun | ||
| Opening equity attributable to shareholders of the Parent Company | 2,707 | 2,707 |
| Closing equity attributable to shareholders of the Parent Company | 3,864 | 3,864 |
| Net effects of IFRS 16 on profit after tax | 24 | |
| Profit after tax excluding effects of IFRS 16 | 187 | |
| Closing equity attributable to shareholders of the Parent Company, excluding effects of IFRS 16 | 3,888 | |
| Average equity attributable to shareholders of the Parent Company, excluding effects of IFRS 16 | 3,298 | |
| Return on equity, excluding effects of IFRS 16 (%) | 1.4 |
| Net debt, Net debt/Adjusted EBITDA, RTM excluding effects of IFRS 16 SEK million |
|
|---|---|
| Non-current interest-bearing liabilities | 6,040 |
| Less: non-current lease liabilities pertaining to properties recognised on the Lease liability line | -3,803 |
| Current interest-bearing liabilities | 2,046 |
| Less: current lease liabilities pertaining to properties recognised on the Lease liability line | |
| Less: cash and cash equivalents | -238 |
| Net debt excluding effects of IFRS 16 | 3,525 |
| Adjusted EBITDA, RTM, adjusted for IFRS 16 | 677 |
| Net debt/Adjusted EBITDA, RTM, excluding effects of IFRS 16 | 5.2 |
| Equity/assets ratio excluding effects of IFRS 16 SEK million |
|
|---|---|
| Total equity, excluding effects of IFRS 16 | 3,888 |
| Total assets | 13,861 |
| Less: right-of-use assets attributable to property | -4,292 |
| Less: Effects of IFRS 16 on deferred tax are recognised on the Deferred tax assets line | |
| Less: Effects of IFRS 16 on prepaid rents are recognised on the Prepaid expenses and accrued income line | |
| Total assets excluding effects of IFRS 16 | 9,562 |
| Equity/assets ratio (%) | 40.7 |
Note 9 Definitions and purpose
The definition of operating cash flow has been changed. As of the interim report for the first quarter of 2019, calculations have been based on Adjusted EBITDA, and cash flows related to increased capacity/growth have been excluded to create better visibility of the underlying cash flows for the growing proportion of Own Management, and for better comparability of the cash conversion rate. The comparative figures have been restated.
The definition of organic growth has changed to also include adjustment for currency. The comparative figures have been restated.
In 2019, alternative performance measures are presented where the effects of IFRS 16 are eliminated to facilitate analysis with the comparative year.
| Key financial figures | Definition and calculation | Purpose | |
|---|---|---|---|
| Growth (%) | Growth consists of the increase in sales in relation to the comparative period. |
This key figure is used to follow up the com pany's sales increase |
|
| The period's increase in net sales/Net sales in the period of comparison |
|||
| Acquired growth (%) | The period's net sales growth from acquisitions/the comparative period's net sales |
The key figure used to monitor the proportion of the company's sales growth generated through acquisitions |
|
| Currency effect on growth (%) | The increase in net sales for the period at tributable to change in exchange rates/Net sales in the comparative period |
The key figure used to monitor the proportion of the company's sales growth generated through exchange-rate fluctuations |
|
| Organic growth (%) | The increase in net sales for the period adjusted for acquisitions, divestments and currency/Net sales in the comparative period |
This key figure is used when analysing un derlying sales growth driven by comparable units between different periods |
|
| Operating profit (EBIT) | Profit for the period before financial items and tax |
The key figure used to monitor the company's profit generated by operating activities. |
|
| Total operating income – Operating expenses | This key figure enables comparisons of profitability between companies/industries |
||
| EBITA | Operating profit before amortisation and impairment of intangible assets |
This key figure is used to follow up the com pany's profit generated by operating activi |
|
| Operating profit (EBIT) + Amortisation and impairment of intangible assets |
ties. This key figure enables comparisons of profitability between companies/industries |
||
| Items affecting comparability | Items related to events in the company's operations that impact comparability with profit during other periods. Include: |
The key figure of Items affecting compara bility is used to achieve a fair comparison of the underlying development of business |
|
| - Transaction costs attributable to major acquisitions |
operations | ||
| - Major re-organisations | |||
| Adjusted EBITA | Operating profit before amortisation and impairment of intangible assets adjusted for items from events in the company's oper ations that affect comparisons with profit during other periods |
The key figure is used to follow up the company's profit generated by operating activities in order to obtain a fair comparison of the underlying development of business operations. This key figure enables compar |
|
| EBITA + Items affecting comparability | isons of profitability between companies/ industries |
| Key financial figures | Definition and calculation | Purpose |
|---|---|---|
| EBITDA | Operating profit before depreciation, amor tisation and impairment of intangible and tangible assets |
The key figure used to follow up the compa ny's profit generated by operating activities. This key figure enables comparisons of profit |
| Operating profit (EBIT) + Depreciation, am ortisation and impairment of tangible and intangible assets |
ability between companies/industries | |
| Adjusted EBITDA | Operating profit before depreciation/amor tisation and impairment of intangible and tangible assets adjusted for items from such events in the company's operations that affect comparisons with profit from other periods |
This key figure is used to follow up the com pany's profit generated by operating activi ties with a fair comparison of the underlying development of the business operations. This key figure enables comparisons of profitabili ty between companies/industries |
| EBITDA + Items affecting comparability | ||
| Operating cash flow | Total cash flow from operating activities excluding tax, net financial items and items affecting comparability, as well as cash flow from investing activities excluding acquisi tions and divestments of operations |
This key figure shows the cash flow from the company's operations, excluding busi ness combinations, company divestments, financing, tax and items affecting compa rability and is used to follow up whether the |
| Adjusted EBITDA + Changes in working capi tal + Cash flow from investing activities excl. acquisitions and divestments of subsidiaries + adjustments for cash flow from investing activities related to increased capacity/ growth |
company is able to generate a sufficiently positive cash flow to maintain and expand its operations |
|
| Free cash flow | Total cash flow from operating activities and cash flow from investing activities excluding acquisitions and divestments of operations |
This key figure shows cash flow from op erating activities including cash flow from investing activities excluding acquisitions |
| Cash flow from operating activities + Cash flow from investing activities excluding ac quisitions and sales of subsidiaries |
and divestments of operations and is used because it is a relevant measure for investors to be able to understand the Group's cash flow from operating activities |
|
| Cash conversion (%) | Cash conversion as a percentage is defined as operating cash flow divided by adjusted EBITDA |
The key figure used as an efficiency measure of the proportion of a company's profit that is converted to cash |
| Operating cash flow/Adjusted EBITDA | ||
| Net debt Net debt /Adjusted EBITDA, RTM |
The Group's interest-bearing liabilities ex cluding pension provisions adjusted for cash and cash equivalents |
This key figure is a measure of the company's debt/equity ratio and is used by the company to assess its capacity to meet its financial |
| Interest-bearing liabilities – cash and cash equivalents |
commitments | |
| Net debt/Adjusted EBITDA is a measure of the debt/equity ratio defined as the closing balance for net debt in relation to rolling adjusted EBITDA. |
The key figure used to monitor the level of the company's indebtedness to ensure that financial covenants are met |
|
| Net debt/Adjusted EBITDA, RTM | ||
| Return on equity (%) | Return on equity shows the company's return on the capital provided by its owners |
This key figure is used to show the returns generated on the capital that shareholders |
| Profit for the period/Equity (average equity at the beginning and end of the period) |
have invested in the company | |
| Operating profit (EBIT) excluding effects of IFRS 16 |
Profit for the period before financial items and tax, adjusted for the effects of IFRS 16 EBIT + net effects of IFRS 16 on EBIT |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Key financial figures | Definition and calculation | Purpose |
|---|---|---|
| Operating margin (EBIT) excluding effects of IFRS 16 |
Operating profit adjusted for the effects of IFRS 16 as a percentage of net sales Operating profit (EBIT) excluding effects of IFRS 16/Net sales |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| EBITA excluding effects of IFRS 16 | Operating profit before amortisation and impairment of intangible assets, adjusted for the effects of IFRS 16 EBITA + net effects of IFRS 16 on EBITA |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Operating margin (%) | Operating profit as a percentage of net sales. Operating profit (EBIT)/Net sales |
This key figure is used to follow up the per centage of net sales from operations that remains to cover interest payments and tax and to generate a profit after the company's costs have been paid |
| Adjusted EBITA excluding effects of IFRS 16 |
Operating profit before amortisation and impairment of intangible assets adjusted for items from such events in the company's op erations that affect comparisons with profit from other periods, adjusted for the effects of IFRS 16 Adjusted EBITA + net effects of IFRS 16 on EBITA |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| EBITDA excluding effects of IFRS 16 | Operating profit before depreciation, amor tisation and impairment of intangible and tangible assets, adjusted for the effects of IFRS 16 |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Adjusted EBITDA excluding effects of IFRS 16 |
Operating profit before amortisation and impairment of intangible assets adjusted for items from such events in the company's op erations that affect comparisons with profit from other periods, adjusted for the effects of IFRS 16 Adjusted EBITDA + net effects of IFRS 16 on EBITA |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Operating cash flow excluding effects of IFRS 16 |
Total cash flow, adjusted for the effects of IFRS 16, from operating activities excluding tax, net financial items and items affecting comparability and cash flow from investing activities excluding acquisitions and disposal of units Adjusted EBITDA + Changes in working capi tal + Cash flow from investing activities excl. acquisitions and divestments of subsidiaries + adjustments for cash flow from investing activities related to increased capacity/ growth |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Cash Conversion (%) excluding effects of IFRS 16 |
Cash generation or Cash conversion as a percentage is defined as operating cash flow divided by Adjusted EBITDA, adjusted for the effects of IFRS 16 Operating cash flow excluding the effects of IFRS 16/EBITDA excluding the effects of IFRS 16 |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Key financial figures | Definition and calculation | Purpose |
|---|---|---|
| Free cash flow excluding effects of IFRS 16 |
Total cash flow from operating activities and cash flow from investing activities excluding acquisitions and divestments of operations, adjusted for the effects of IFRS 16 Free cash flow – net effects of IFRS 16 on EBITDA – Change in operating receivables/ liabilities attributable to IFRS 16 + interest payments attributable to IFRS 16 |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Net debt excluding effects of IFRS 16 | The Group's interest-bearing liabilities ex cluding pension provisions adjusted for cash and cash equivalents Net debt – lease liabilities related to proper ties |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Net debt / Adjusted EBITDA, RTM ex cluding effects of IFRS 16 |
Net debt/Adjusted EBITDA excluding the ef fects of IFRS 16 is a measure of the debt/eq uity ratio defined as the closing balance for net debt, adjusted for the effects of IFRS, in relation to rolling adjusted EBITDA, adjusted for the effects of IFRS 16 Net debt excluding the effects of IFRS 16/ Adjusted EBITA excluding the effects of IFRS 16 RTM |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Profit before tax excluding effects of IFRS 16 |
Profit before tax, adjusted for the effects of IFRS 16 Profit before tax + net effects of IFRS 16 on profit before tax |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Profit after tax excluding effects of IFRS 16 |
Profit after tax, adjusted for the effects of IFRS 16 Profit before tax excluding the effects of IFRS 16 + effects of IFRS 16 on deferred tax |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Earnings per share before dilution, excluding effects of IFRS 16 |
Earnings per share before dilution, excluding the effects of IFRS 16 on profit for the year Profit after tax excluding the effects of IFRS 16 /Average number of shares before dilution |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Earnings per share after dilution, ex cluding effects of IFRS 16 |
Earnings per share before dilution, excluding the effects of IFRS 16 on profit for the year and equity Profit after tax excluding the effects of IFRS 16 /Average number of shares after dilution |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Return on equity, excluding effects of IFRS 16 |
Profit after tax excluding the effects of IFRS 16 /Average equity attributable to sharehold ers of the Parent Company, excluding the effects of IFRS 16 |
This key figure is used to facilitate a com parison with the preceding period, since IFRS 16 is only applied to the period's financial statements |
| Equity/assets ratio (%) | The equity/assets ratio is used to show the proportion of assets that is financed by equity Equity/Total assets |
This key figure shows the percentage of total assets financed with equity and enables an analysis of the company's long-term finan cial strength and ability to withstand losses |
| Comparable units | Comparable units include units that have been in Ambea's operation for at least 13 months. |
This key figure is used to show the EBITA margin in units with a stable status to com pare with the total EBITA margin, which also includes start-up units. |
Quality management in the second quarter of 2019
Summary
- All of Aleris's operations in Sweden have now implemented Ambea's quality index. Work is now being initiated in all operations to enhance the quality areas that are not in line with Ambea's quality requirements. Accordingly, the index has declined somewhat in both Vardaga and Nytida. Compared with the first quarter, the Quality and HR Flash1 decreased somewhat during the second quarter, in Vardaga from 7.4 to 6.8 and in Nytida from 7.0 to 6.9.
- During the quarter, Vardaga started a training programme to improve employees' skills in palliative care (care in the last phase of life). For each resident, four to five palliative representatives are trained, who can then lead the work in social care during the last phase of life and support colleagues in the operation.
- Stendi underwent reorganisation processes during the quarter after it was decided to replace the former, decentralised quality structure with a central quality organisation. As of 1 June, quality is part of the staff functions under the business area manager. Focus on this work will be intensified moving forward and the new Quality and Development department has started to integrate Ambea's quality procedures and management systems in Stendi.
1 The quality and HR flash is Ambea's tool for follow-up of the Group's quality and HR work. It is sent out to all operations in Nytida and Vardaga every month.

Daniel Mårs, Kristina Alexandersson and Anna Bossen (not in the photo) developed Vardaga's new palliative care training course
- All of the regions in Stendi's operations for children and young people have been inspected by the inspection authority, all with favourable results and without major deviations.
- In May, a user survey was conducted among care receivers at Altiden's elderly care facilities. The results showed, for example, that 97.3 per cent of the residents could recommend Altiden to others.
Awards and distinctions
- • Gender equality: Again this year, Ambea was included in the Allbright Foundation's list of the stock exchange's companies with the highest gender equality. Since the end of April, Ambea's management group has comprised four women and three men, while eight of ten listed companies have male-dominated management groups according to the Allbright report.
- • Talent prize: Murtada Hacham, an employee of Altiden's home care organisation in Glostrup, won the 2019 Welfare Talent Prize after being nominated by his colleagues. The award, which is supported by the Danish Union of Public Employees and the PenSam pension and life insurance company, is presented annually to honour an employee who makes a special effort every day for society's elderly, children and sick.

57%
The quarter in figures (Sweden)
- The share of serious deviations during the second quarter (grade 4) was somewhat higher compared with the preceding quarter, but was still at a low level (0.17 per cent).
- Two complaints were made in accordance with Lex Sarah, both in Vardaga. The Swedish Health and Social Care Inspectorate (IVO) has issued its decision for one of the complaints and the case is now closed without any action required. One Lex Maria complaint was made, also in Vardaga. IVO has not yet made a decision. In the preceding quarter, three Lex Sarah complaints were submitted and no Lex Maria complaints.
- Individual complaints investigated by the IVO: Three separate complaints were submitted pertaining to Vardaga's operations, but IVO has not yet made a decision in any of these cases. Two complaints regarding Nytida's operations were submitted, and a decision has been made in one of the cases, with IVO making some criticism. In the preceding quarter, eleven separate complaints were submitted.
Kvinnor Män
• Inspections: IVO carried out 16 inspections of Nytida's units and to date, nine decisions have been issued, seven without criticism and two with criticism. For Vardaga, an inspection was conducted and a decision containing criticism was received.